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ABSTRACT
Phospholipase A2 (PLA2) is an enzyme that hydrolyzes the sn-2-ester bond of membrane
phospholipids and liberates arachidonic acid, which is converted to eicosanoids that act as potent
mediators of inflammation and allergy. As such this enzyme plays a crucial role in many
homeostatic physiological and immunologic processes and disease progression. PLA2s undergo
substantial increase in activity upon binding to cellular membranes. This effect of interfacial
activation is well recognized, yet its structural and physical aspects are poorly understood. In this
work, we have employed the interdisciplinary methods of molecular biology, biochemistry,
biophysics, bioinformatics and computational biology, in order to elucidate the structure-function
relationships mediating the interfacial activation of human group IIA and group IB PLA2
isoforms. We have evaluated the structural and functional consequences of two conservative,
single residue substitutions, located at key membrane-binding and substrate-binding positions of
hIIA PLA2. We have also evaluated a human group IB fragment (hIBΔN10), missing the first 10
N-terminal residues which make up the N-terminal alpha helix, as well as a chimeric enzyme
substituting the N-terminal alpha helix of hIB PLA2 with that from hIIA PLA2 (hIIA/IB PLA2).
We have compared the engineered proteins against both the hIIA and hIB PLA2 native enzymes
and their N-terminal peptides, N10-hIB and N10-hIIA, respectively. We have developed and
used a novel multidisciplinary approach in order to position the segmentally labeled hIB PLA2
and hIIA/IB chimeric PLA2s at the membrane surface. The results of this work provide
significant insight into the understanding of the physical aspects of interfacial activation by
determining the precise membrane binding modes of PLA2 isoforms and identifying certain
amino acid residues and whole protein segments that play key roles in membrane binding,
activation, and involved allosteric conformational effects in PLA2s.
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CHAPTER ONE: INTRODUCTION

Biological membranes are composed of a fluid lipid bilayer interspersed with the
hydrophobic domains of proteins and other biomolecules. The bilayer itself is made up of a
combination of glycerophospholipids, sphingolipids, and sterols, with glycerophospholipids as
the major component. Glycerophospholipids are amphipathic molecules composed of a glycerol
backbone with a polar head group and two hydrocarbon chains. The head group, such as choline,
ethanolamine, serine, glycerol, or inositol, is attached through a phosphodiester bond to the sn-3
position of the glycerol backbone (Figure 1). In mammalian tissues phosphatidylcholine
(lecithin) is the predominant membrane phospholipid. In bacteria, the major membrane
phospholipid is phosphatidylglycerol. The hydrophobic components of the glycerophospholipid
are long chain fatty acids attached by ester bonds at the other two positions of the glycerol
backbone. The sn-1 position is usually occupied by a 16 or 18 carbon, saturated fatty acid or long
chain alcohol, attached to the glycerol by either an ester or an ether bond, respectively. The sn-2
position is usually occupied by an 18 to 20 carbon, unsaturated fatty acid residue linked by an
ester bond. Some common fatty acids found in biological membranes are presented in Table 1.
Besides serving as a structural component of the bilayer, the glycerophospholipids sequester
signal transduction second messengers within their functional groups. Phospholipases A1, A2, C
and D participate in signal transduction by cleaving specific ester bonds of the
glycerophospholipids releasing unique second messengers. The class of second messenger
depends on the type of fatty acid, head group, phosphate or lysophospholipid released. Figure 2
shows the specific ester bonds cleaved and representative hydrolysis products for each of these
phospholipases.

1

sn-3

sn-2 sn-1

Serine
Choline

X

Glycerol

Inositol 4,5-bisphosphate

Ethanolamine

Head groups

Figure 1 Glycerophospholipids
The head group of the glycerophospholipid (X) determines the overall electrostatic nature of the
lipid. Phosphatidyl-choline and -ethanolamine are zwitterionic lipids, -glycerol and -serine are
anionic, and -inositol 4,5-bisphosphate has a net charge of -4 at pH 7.
Table 1 Fatty Acids

Saturated and unsaturated fatty acids commonly found in glycerophospholipids.
Adapted from Biochemistry, by Garrett and Grisham 1.
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Figure 2 Phospholipase Cleavage Sites
Representative hydrolysis products and cleavage sites for Phospholipases A1, A2, C and D

3

Phospholipases are classified as interfacial enzymes, because the interaction between the
water soluble enzyme and its water insoluble substrate must occur at the interface between the
aqueous solvent and aggregated phospholipids. Phospholipase A2 (PLA2), analogous to trypsin
or lysozyme in solution enzymology, is considered the prototype for the characterization of
interfacial enzymes 2. For PLA2, the substrate aggregates are found in the form of small mixed
micelles, such as dietary lipids and bile salts 3, intermediate heterogenous aggregates such as
LDL or HDL 4; 5; 6, or the large continuous surfaces of biological membranes such as intracellular
nuclear membranes 7; 8; extracellular plasma membranes 9; 10; localized intestinal lumina 11; 12; or
mobile erythrocytes 13; 14 and bacteria 15; 16; 17. The global regulation of this enzyme is related to
its general function: snake venom PLA2 is injected from salivary glands into prey; honey bee
venom PLA2 is injected from the venom gland as a defense mechanism; pancreatic PLA2 is
secreted as a zymogen into the digestive tract

18; 19

to assist in the metabolism of dietary lipids;

and synovial PLA2 (originally isolated from the synovial fluid of patients with rheumatoid
arthritis), is secreted in tears to protect the eye from bacterial infection

20; 21

. The local or

molecular mechanism regulating the interaction of PLA2 with its substrate is related to its
molecular function: cytosolic PLA2 (cPLA2) is constitutively expressed and regulated by
phosphorylation

22; 23; 24

; secreted PLA2s (sPLA2) are regulated by localized expression

shuttling to internal vesicles by heparin sulfate mediated endocytosis

25

or

26

; as first responders for

the innate immune system, sPLA2s are sequestered in granulocytes 27; 28; or localized to potential
avenues of entry such as the mucous membranes of the respiratory

29; 30; 31

and gastrointestinal

tracts 32, or in skin keratinocytes 33.
As seen in Figure 2, the hydrolysis products for PLA2 are a lysophospholipid and a free
fatty acid. The most significant products of PLA2 hydrolysis, as it pertains to human health and

4

disease, are arachidonic acid
platelet activating factor

34; 35

and a lysophospholipid that can be further metabolized into

1

. Arachidonic acid is the precursor to eicosanoids such as

prostaglandins, leukotrienes, and thromboxanes. As their name implies, these products were first
identified in prostate glands, leukocytes, and thrombocytes. The eicosanoids mediate many
diverse physiologic functions such as reproduction
contractions

38; 39

, blood clot formation

40

36

, blood pressure

37

, and the classic symptoms of inflammation: rubor,

tumor, calor, dolor (redness, swelling, heat and pain)

41; 42

. PLA2 has been implicated in many

disease states which correlate to aberrations of its native function: asthma
Crohn's disease

45; 46

, premature labor

, smooth muscle

47

, cancer progression

29; 43

, arthritis

44

,

48; 49

, and neurodegenerative

diseases50.
Because of the pivotal role of PLA2s in inflammation, allergy and tumorigenesis, these
enzymes have been the focus of extensive research. Much is understood about the general
properties of these enzymes however, each new result adds to the expanding complexity of the
PLA2 paradigm. From an initial classification of two types of PLA2s, venom and pancreatic, has
grown a superfamily of interrelated enzymes. Hydrolysis of the sn-2 ester bond of glycerol
phospholipids is the only characteristic shared by every member of the PLA2 superfamily, which
have been classified into groups according to common features such as amino acid sequence,
disulfide bonding pattern, size, cellular location or catalytic requirements for calcium. The
groups presently established, and some of the general characteristics, including the common
sources of the enzyme, are presented in Table 2.

5

Table 2 Phospholipase A2 Superfamily

Phospholipase A2 superfamily sorted by cellular location. Designation: secreted: sPLA2, cytosolic: cPLA2, calcium independent: iPLA2,
51; 52; 53
and Platelet-activating factor acetylhydrolase: PAF. Compiled from reviews by Dennis, Murakami and Singer
6

Because of their significance to health and disease, we have directed the focus of this
work on two human PLA2 paralogs, the pancreatic group IB (hIB PLA2), and the synovial group
IIA (hIIA PLA2). These two enzymes share a highly conserved primary sequence

54

with the

other members of groups I, II, V and X, which will be referred to in this work as shPLA2
(homologous sPLA2). The high sequence homology between these isoforms results in nearly
superimposable three dimensional structures, consisting of three alpha helices and a small
antiparallel beta sheet. Figure 3, a schematic representation of hIIA PLA2, illustrates the general
relationship between the secondary structure and primary sequence. This same relationship can
be applied to any other shPLA2 through a core numbering system (Table 3), which is based on
bovine IB PLA2 in order to facilitate comparisons between isoforms 54. The first 10 – 12 amino
acids make up the amphipathic N-terminal alpha helix (H1), followed by a loop containing
several residues that contribute to substrate binding and calcium coordination. The second alpha
helix (H2), residues 40-58, contains the catalytic residue His48. H2 is followed by a short loop of
surface interacting residues, as well as Lys69 (Tyr69 in hIB PLA2), a key participant in substrate
stabilization. The loop is followed by a beta sheet, spanning residues 74-85. One of the cysteines
unique to group IB PLA2 (Cys77) connects the beta sheet through a disulfide bridge to the other
group specific cysteine in the N-terminal helix (Cys11), functionally connecting the two
structures. The apparent allosteric relationship between membrane binding and enzyme
activation, mediated by the group IB PLA2 N-terminal helix

55; 56

, could be the effect of this

group specific structure. The third alpha helix (H3), residues 91-109, contains the catalytic
residue Asp99, as well as four cysteines that anchor H3 to H2 and the calcium binding loop. The
C-terminal loop contains a short extension unique to group IIA PLA2, linked by a disulfide
bridge to H2 through a group II specific cysteine at its terminus.

7

Figure 3 hIIA PLA2
The alpha helical residues are blue, beta sheet residues are brown, loops are green and disulfides gold.
The active site residues are shown in red. Refer to body of text for further details.

The tertiary structure, as revealed by both X-ray and NMR methods, is relatively oblong
with a nearly planar surface which interacts with the aggregated substrate, called the interfacial
binding surface (IBS) 57. The substrate enters the enzyme through an opening located on the IBS
into the substrate binding channel. The entrance is surrounded by a ‘collar’ of hydrophobic
residues facilitating entry by the hydrophobic substrate. The catalytic site, located along one wall
of the substrate binding channel, includes a calcium ion cofactor which also coordinates the
substrate sn-3 phosphate group. The other wall of the channel is made up of residues lining the
internal face of the N-terminal helix. Several hydrophobic residues from H2 and H3 make up the
length of the channel, which terminates at a small opening on the dorsal surface of the enzyme.
8

Table 3 Sequence alignment

Bovine IB serves as the core sequence numbering system, human IB and IIA PLA2 numbering are also presented
9

Two similar mechanisms have been proposed for the specific catalysis by shPLA2s. The
first is analogous to the triad mechanism of serine protease

58

, and the second is a proposed

calcium-coordinated oxyanion mechanism 59. The catalytic triad mechanism for shPLA2 (Figure
4), consists of His48, Asp99 and a conserved water molecule (w6). In this scenario, the sn-2
carbonyl of the phospholipid substrate is coordinated by the active site calcium, inducing a
dipole across the carbonyl making it energetically favorable for a nucleophilic attack. The Asp99
is hydrogen bonded to the εNH of His48, which acts as a general base to deprotonate the
conserved water, generating the attacking OH- nucleophile. The attacking hydroxide nucleophile
facilitates the formation of a tetrahedral intermediate, which quickly decomposes as the proton is
transferred from the His48 δN to the sn-2 O- of the lysophospholipid leaving group. The rate
limiting step is presumed to be the formation of a tetrahedral intermediate while the δN of H48 is
protonated.
The oxyanion mechanism (Figure 5) is similar to the catalytic triad mechanism, with the
exception of a second conserved water (w5) which is coordinated to the active site calcium. This
water becomes the attacking nucleophile through w6, which is hydrogen bonded to His48. The
delocalization of electrons across the hydrogen bond network: Asp99-His48-w6-w5-Ca2+,
facilitates the transfer of the proton from w5 to w6, and then from w6 to the leaving group. In this
mechanism, the decomposition of the tetrahedral intermediate is the rate limiting step. A
molecular dynamics simulation of this process

59

using only w6, demonstrated the movement of

the water from the w6 to the w5 positions, before a proximal water moved into the w5 position.

10

Figure 4 Catalytic mechanism I
Catalytic Triad mechanism with a conserved water as nucleophile.
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Figure 5 Catalytic mechanism II
Oxyanion mechanism with two conserved water molecules, the second water acts as nucleophile.
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The catalytic activity of these enzymes is directly related to its substrate specificity. As
interfacial enzymes, the binding of a single substrate to the catalytic site is dependent upon
effective binding of the enzyme to the aggregate containing the single substrate such as micelles
or membranes. Therefore the overall rate of hydrolysis is a reflection of not only the catalytic
activity of the enzyme, but of the preliminary binding step as well. The Michaelis-Menten kinetic
paradigm is used to evaluate water soluble enzymes and their water soluble substrates. An
expanded kinetic scheme has been proposed for interfacial enzymes, incorporating the
prerequisite binding step 60 (Figure 6).

Figure 6 Kinetic scheme
Schematic diagram of the interaction between an interfacial enzyme and its aggregated substrate.
E* denotes the membrane bound enzyme, S the single phospholipid substrate and P the products,
shown in red. Kd is the dissociation constant, Ks* the constant for the association of the monomeric
substrate with the enzyme, K# the constant for interfacial activation, and Kcat, the constant for the
rate of catalysis.

Through the kinetic dissection of the shPLA2 isoforms, the maximum reaction velocity,
binding affinities for substrate and inhibitors, and responses to reaction conditions have been
identified 2. Various substrate specific modulators of enzymatic function, such as liquid ordered
or gel phases of the aggregate 61, surface topography 62; 63, or headgroup charge 15; 64, have been
identified. What has yet to be defined is the specific mechanism(s) by which the physical nature
of the substrate induces an observable change in the catalytic rate of the enzyme: starting with a
low to moderate rate, followed by a sudden burst of activity at the maximum rate, coined
interfacial activation.
13

For group I and II PLA2s, this apparently induced activation is pronounced on
zwitterionic aggregates, for which these sPLA2s have a low binding affinity. The accelerated
activity is shown to be mediated by the buildup of anionic products within the aggregate

65

,

leading to a tighter binding of the enzyme through interactions with cationic residues on the IBS.
However, the tightness of the interaction does not necessarily induce an increase in activity, as
site specific mutations have resulted in enzymes that bind tighter than the wild type, but have a
lower specific activity

66; 67

. Atomic resolution structures, revealing either no or small structural

changes in enzymes with or without bound substrate analogs or inhibitors

66; 68; 69

, resulted in

conflicting conclusions as to structural changes mediating interfacial activation. Many substrate
associated and enzyme associated contributors have been identified, but as yet no unifying
mechanism has been proposed. By focusing on two well characterized human sPLA2 isoforms,
pancreatic group IB and synovial group IIA, this work endeavors to elucidate the subtle
structural determinants of function at the enzyme-substrate interface, in order to provide insight
into the understanding of interfacial activation at a molecular level.
Between the homologous groups of sPLA2s (I, II, V and X), there are several
characteristic differences in primary structure, as well as several invariant residues which are
specific for a particular group or species. These relatively small structural differences contribute
to unique functional specificities. For example, group IB enzymes demonstrate a low to
moderate activity toward zwitterionic substrates

55; 70

, but human group IIA, a highly cationic

enzyme, does not bind to zwitterionic substrates, but only demonstrates appreciable membrane
binding and activity when the membranes contain at least 15 mol% of anionic lipids

71

. This

affinity for anionic lipids enables hIIA PLA2 to act as an effective antimicrobial in human tears16,
hydrolyzing bacterial membranes which have a high content of phosphatidylglycerol, an anionic

14

lipid. The differences in function and specificity of the shPLA2s are mediated by isoformspecific amino acid residues found in the non-homologous regions of the enzymes. It is these
types of subtle differences that make the shPLA2 enzymes an excellent model for studying
structure-function relationships.
The N-terminal 10-12 residues of group I and II PLA2s constitute a functionally
important amphipathic alpha helix. The N-terminal helix contributes to membrane binding
through several cationic and nonpolar residues along one face of the helix, and to substrate
entrance into the active site cleft by several hydrophobic residues along the opposite face of the
helix (Figure 7). The conserved hydrophobic residue at position 3 enhances binding to
zwitterionic lipids such as phosphatidylcholine (PC), a major constituent of the outer leaflet of
plasma membranes. A tryptophan in this position is unique to the group IB PLA2 isoform: all
other shPLA2s have a valine or other hydrophobic residue in the third position. Mutation of the
Trp3 of bovine group IB PLA2 to Ala caused a 3 to 7 fold decrease in activity of the enzyme
toward dimyristoyl-phosphatidylmethanol (DMPM) membranes or diheptadecyl PC micelles 72.
Conversely, the introduction of a Trp into the 3rd position of hIIA PLA2, which lacks the ability
to bind to neutral membranes, resulted in a mutant with a relatively high affinity to bind to and
hydrolyze PC membranes

73; 74; 75

. Interestingly, Trp mutations of the other seven nonpolar

residues that constitute the hydrophobic collar of hIIA PLA2, had little or no increased activity 74.
The enhanced activity of the Trp3 mutant towards zwitterionic substrate was interpreted in terms
of Trp mediated stronger binding of the enzyme to the membrane

73; 74

. The collective data

however are inconsistent, with a wide range of binding affinities and rates of activity, including
variations in affinity toward anionic substrates in various forms such as micelles or LUVs.

15

Figure 7 hIIA PLA2 N-terminal helix
Shiffer-Edmundson wheel projection of the N-terminal helix of hIIA PLA2.The first residue (Ala1) is
near the top of the wheel, the membrane interacting residues from Lys7 to Leu2, are at the bottom.

The specific catalytic activity of the enzyme is dependent upon the substrate binding to
the enzyme’s active site. Two residues, Phe5 and Ile9 are invariant in all but group V shPLA2s. A
single study of bovine IB PLA2, substituting Phe5 by hydrophobic or aromatic residues of either
smaller or larger size, reported reduced activity for all mutants 76. Atomic-resolution structures of
group I and II PLA2s with bound substrate-mimic inhibitors, show intimate van der Waals
contacts between the side chain of Phe5 and the hydrophobic moieties of the bound inhibitor
16

77;

78; 79; 80

, suggesting that Phe5 may serve to facilitate a productive enzyme-substrate interaction.

These mutational studies clearly underscore the functional importance of Trp3 and Phe5.
The focus of this work has been to define structure-function relationships involved in
interfacial activation of human group IB and IIA PLA2s upon binding to aggregated substrate,
using an interdisciplinary approach combining molecular, biochemical, biophysical and
computational methods. In order to determine the precise membrane binding modes of group I
and II PLA2s, we have created a semisynthetic, segmentally isotope labeled hIB PLA2, as well as
a chimeric PLA2 (hIIA/IB PLA2) containing the first 10 N-terminal residues of hIIA PLA2
ligated to a fragment of hIB PLA2 (hIBΔN10 PLA2) lacking the first 10 residues

81; 82

. Two

single residue mutants of hIIA PLA2 substituting Trp3 and Phe5 with tryptophan (V3W, F5W),
have been produced in order to elucidate the mechanism by which a minor structural change: a
single amino acid substitution, can cause dramatic functional changes in the catalytic activity of
these relatively small, stable enzymes. We have employed lipid aggregates in a variety of forms:
micellar, vesicular, and supported bilayers, varying the compositional concentrations of negative
lipids, in order to search out the subtleties of behavior of native and mutant group I and II PLA2
molecules. The functional roles of the native Trp3 were evaluated through parallel experiments
with hIB PLA2. We have determined structural consequences for the substitution of a
phenylalanine for a bulkier tryptophan in the substrate binding pocket of human group IIA PLA2.
Our results present considerable methodological advances for the determination of the
precise membrane binding mode of peripheral membrane proteins; uncover isoform-specific
membrane binding modes, as well as conformational and stability changes in shPLA2s during
membrane binding; and identify dramatically different activity and conformational changes in
hIIA PLA2 induced by Trp mutations of closely located residues. The latter are interpreted in
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terms of distinct effects of Trp at the membrane-binding versus substrate-binding sites of hIIA
PLA2 on conformational changes accompanying the interfacial activation of the enzyme. The
results of this work identify the N-terminal helix of group I and II PLA2s as a regulatory site of
the enzyme, and implement the idea that not only the membrane binding strength, but depth of
membrane insertion and especially the orientation of the enzyme to the membrane, are critical
determinants for the function of shPLA2s.
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CHAPTER TWO: MATERIALS AND METHODS
Materials Miniprep and PCR recovery kit were obtained from Qiagen (Valencia, CA);
primers designed to incorporate point mutation were from Molecula (Herndon, VA); pGEM-T
vectors and DH-5α bacteria were from Novagen (Madison, WI); and restriction enzymes were
from Amersham (Piscataway, NJ). The sPLA2 activity kit was from Cayman Chemical (Ann
Arbor, MI) and the Silver Stain kit from Invitrogen (Carlsbad, CA).
The lipids, 1-palmitoy-2-oleoyl-sn-glycero-3-phosphocholine (POPC); 1-palmitoy-2oleoyl-sn-glycero-3-phosphoglycerol (POPG); and 1-palmitoy-2-stearoyl-(6,7) dibromo-snglycero-3-phosphocholine (Br2PC), brominated at positions 6-7, 9-10, or 11-12; were from
Avanti Polar Lipids (Alabaster, AL). 1,2,bis-(1-pyrenedecanoyl)-sn-glycero-3-phosphocholine
(BisPy-PC), and N-(fluorescein-5-thiocarbamoyl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (FPE) were from Molecular Probes (Eugene, OR). The bacterial vector with the
human group IIA PLA2 gene, mutated at the first position from Asparagine to Alanine to
facilitate removal of the initiator methionine in E. coli (N1A hIIA PLA2), was kindly provided
by Prof. David Wilton (University of Southampton, UK). All proteins have been lyophilized out
of pure water and resuspended in the appropriate buffers for each experiment. Experimental
buffer composition was 50 mM HEPES (pH 7.4 at 25 °C), 100 mM NaCl, 1 mM NaN3, 1 mM
EGTA, unless otherwise stated. Due to the highly cationic nature of the hIIA PLA2 isoform, all
glassware, plastic tips and tubes were first coated with Sigmakote (Sigma, St Louis, MO), to
reduce loss of protein by adsorbtion to any contact surfaces. The hIB PLA2 N-terminal peptide:
N10-hIB (Ac-Ala-Val-Trp-Gln-Phe-Arg-Lys-Met-Ile-Lys-NH2), and the hIIA PLA2 N-terminal
peptide: N10-hIIA (Ac-Asn-Leu-Val-Asn-Phe-His-Arg-Met-Ile-Lys-NH2) were synthesized by
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Advanced ChemTech (Louisville, KY) and were ~99% pure as confirmed by HPLC and massspectrometry. All other chemicals were obtained from Sigma (St. Louis, Mo).
Production of Recombinant Proteins The plasmid containing the N1A hIIA PLA2 gene
was extracted and purified from the original E. coli clone and sequenced, using a BeckmanCoulter CEQ 2000 XL DNA sequencer (Fullerton, CA). The sequence was analyzed to
determine the flanking restriction sites and primers designed to incorporate point mutations into
the N1A hIIA PLA2 gene. PCR was employed to generate the mutated target gene, using the
original plasmid as template, and the following forward primers: V3W: 5’-TACAT ATG GCC
CTG TGG AAC TTC CAC CGT ATG-3’, F5W: 5’-TACAT ATG GCC CTG GTA AAC TGG
CAC CGT ATG-3’. The same reverse primer was used for both reactions: 5’-TCA TCG ATA
AGC TTC ACT ATT AGC-3’. The PCR product was inserted into pGEM-T easy vector,
sequenced and amplified in E. coli DH-5α. The target was subcloned into the expression vector
pET-21a (+) (NdeI/HindIII restriction sites) and used to transform BL21 (DE3) expression line.
As the first amino acid substitution does not modify the structure or other properties of hIIA
PLA2, the N1A clone is designated hIIA PLA2, and the 3rd and 5th position tryptophan mutants by
the single mutation reference V3W and F5W respectively. Production of human group IB PLA2
and its fragment minus the first 10 residues (hIBΔN10) by recombinant DNA manipulation
techniques is described in Qin et al., 2004 83. Ligation of the N10-hIB peptide and the N10-hIIA
peptide to the hIBΔN10 fragment, which had been uniformly labeled with

13

C, to generate

segmentally labeled full length hIB PLA2 and a chimeric hIIA/IB PLA2 protein is described in
Tatulian et al., 2005 and Qin et al., 2005 81; 82.
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Expression and purification of hIIA PLA2 The human IIA PLA2 protein was expressed
in a minimal medium enriched with

15

N-labeled ammonium chloride (15NH4Cl) and

13

C6-D-

glucose as sole metabolic nitrogen and carbon sources, for NMR experiments. The minimal
medium consisted of 6.8 g/L Na2HPO4, 3.0 g/L KH2PO4, 0.5 g/L NaCl, 1.0 g/L 15NH4Cl, which
was first autoclaved before supplementing with a sterile solution of

13

C6-D- MgSO4*7H2O,

CaCl2*2H2O, Thiamine, FeSO4*7H2O, and carbenicillin at final concentrations of 2.0, 0.494,
0.0147, 0.01, 0.01, 0.2 mg/mL, respectively. hIIA PLA2, V3W and F5W for biophysical
experiments were expressed in standard LB media, with 0.2 mg/mL carbenicillin. The expression
protocol, adapted from Othman et al.,199684, was modified in order to optimize the yield of hIIA
PLA2. The condensed protocol is as follows: Each expression was initiated by the selection of
several large single colonies from 1% ampicillin plates. The plates were cultured from glycerol
stocks stored at -80 °C and incubated overnight at 37 °C. Forty mL for each liter of culture media
was inoculated and incubated overnight at 37 °C on an orbital shaker set to 250 rpm. The
overnight culture was transferred into the expression media. After recording the initial OD600, the
culture was incubated at 37 °C, 250 rpm. Expression was induced with IPTG, 1mM final
concentration, when the corrected OD600 was ≈ 0.6 (corrected OD600 = OD600 - OD600 initial).
Cells were cultured at 37 °C for 6 hrs after induction, before reducing the temperature to 27 °C
and incubated overnight. The cells were harvested by centrifugation at 6,000 rpm for 10 minutes,
and supernatant discarded. Purification of inclusion bodies out of the bacterial cells consisted of
lysing the cells and washing the pellet four times. The first two washes were facilitated by
sonication (on ice, 2 minutes on, 2 minutes off; three times) using a Sonic Dismembrator (Fisher
Scientific, Suwanee, GA), and the third with stirring at ambient temperature for 20 minutes. The
inclusion bodies were pelleted after each wash by centrifugation (12,000 rpm, 4 °C, 30 min) and
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the supernatant discarded. The washes consisted of 50 mM Tris-HCl (pH 8.0 at 4 °C), 50 mM
NaCl, 1 mM EDTA, 1 mM NaN3, supplemented with: 1) 0.4% Na-deoxicholate, 0.4% Triton X100, 0.2 mg/mL lysozyme, 1x stock protease inhibitor; 2) 0.8% Na-deoxicholate, 0.8% Triton X100 and 1x stock protease inhibitor; 3) 1% Triton X-100; and 4) Tris-HCl buffer alone. The
purified inclusion bodies were subsequently denatured in a solution of 6 M Guanidine HCl and
5% β-mercaptoethanol in the Tris-HCl purification buffer, with stirring, at 4 °C overnight. The
refolding of the protein was mediated by gradual dialysis against 0.9 M Guanidine HCl in a 25
mM Tris-HCl buffer (pH 8.0 at 4 °C), supplemented with 5 mM CaCl2, 5 mM L-Cysteine (4x
2L, ~8 hrs each, with stirring at 4 °C). After refolding, the refolding buffer was exchanged by
dialyzing against a low salt binding buffer: 20 mM Tris-HCl (pH 7.4 at 4 °C), 2.5 mM KCl. The
final purification consisted of a two step column chromatography scheme utilizing an ÄKTA
purifier 100 and chromatography columns from Amersham Biosciences (Piscataway, NJ). After
centrifugation (12,000 rpm, 30 min, 4 °C), then the solution passed through a 2 μm syringe filter.
The solution was loaded onto a 20 mL heparin column and washed with three column volumes
of the binding buffer. The protein was eluted with a linear concentration gradient of a high salt
elution buffer: 20 mM Tris-HCl (pH 7.4 at 4 °C), 1.5 M KCl. The active fractions were identified
using the sPLA2 activity kit from Cayman Chemical and pooled. The sample volume was
reduced to 2 mL, using Amicon YM-3000 concentrators (Millipore) and loaded directly onto a
HiLoad 16/60 Superdex 75 column, without exchanging the high salt buffer for the size
exclusion buffer. The protein was eluted from the superdex column at 0.5 mL/min with a size
exclusion buffer: 20 mM Tris-HCl (pH 7.4 at 4 °C), 25 mM KCl, and fractions checked for PLA2
activity. Purity was determined using SDS-PAGE (15% polyacrylamide) and visualized by silver
staining. Only pure, active fractions were collected, pooled and dialyzed against pure water,
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Milli-Q filtered (ddH2O). The final protein concentration was checked using the OD280 and the
protein was lyophilized and stored at -80 °C.
Determination of extinction coefficients One mg of pure protein was weighed and
dissolved in 1 mL ddH2O. The OD280 was measured using a 0.4 cm path length, quartz cuvette
on a Carey 100 double-beam spectrophotometer (Varian Inc., Palo Alto, CA). The adjusted
molecular weight of each protein was calculated from the respective sequences. The extinction
coefficients were derived from the equation A = εcl for the hIB PLA2, hIIA PLA2, V3W and
F5W proteins.
PLA2 activity against phospholipid micelles Specific activity of each protein was
measured using an assay kit specific for sPLA2 from Cayman chemical (Ann Arbor, MI), on a
Cary 100 double-beam spectrophotometer (Varian Inc., Palo Alto, CA). The kit consists of
diheptanoyl-thio-phosphatidylcholine (DHTPC) substrate, 5,5’-dithio-bis-(2-nitrobenzoic acid)
(DTNB) reporter and buffer concentrate. As PLA2 hydrolyzes the thio-lipid substrate, the free
thiol at the sn-2 position of the lysolipid reacts with the DTNB, liberating the chromophore, 5thio-2-nitrobenzoic acid that strongly absorbs around 414 nm. Therefore, the signal at 414 nm
can be used to quantitatively measure the amount of hydrolyzed lipid, using the extinction
coefficient of 5-thio-2-nitrobenzoic acid ε414 = 13,600 M-1 cm-1. The final composition of the
buffer was 25 mM Tris-HCl (pH 7.5), 100 mM KCl, 10 mM CaCl2, 0.3 mM Triton X-100, 0.5
mM DTNB, and 1 mg/mL bovine serum albumin (BSA). The reaction was initiated by the
addition of PLA2 to a final concentration of 0.35 μg/mL to the sample cuvette.
Preparation of large unilamellar vesicles A Liposofast extruder (Avestin, Ottawa,
Canada) with two stacked 100 nm polycarbonate filters, was used to generate large unilamellar
vesicles (LUV) of uniform size. 10 mM stock solutions of lipid in chloroform were aliquoted and
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mixed in desired molar ratios. The solvent was removed under a light stream of compressed
nitrogen, followed by dessication under vacuum for a minimum of 3 hours. The lipid film was
suspended in aqueous buffers and vortexed for 3 minutes. The resulting dispersions were injected
through the extruder until clear (19 passes), and the resultant LUVs were used within 4 hours of
preparation.
Fluorescence and circular dichroism experiments Fluorescence and circular dichroism
(CD) measurements were conducted using a Jasco 810 spectrofluoropolarimeter (Jasco Corp.,
Tokyo, Japan). This particular model is equipped with an additional photomultiplier tube
mounted at 90 degrees for fluorescence measurements and a Peltier water cooled thermostat and
stir plate. CD spectra of protein and appropriate controls were obtained using a 0.2 mm optical
path-length quartz cuvette. Ellipticity, θ, was measured between 260 and 180 nm, with a band
width of 1, scan speed of 100 nm/min and 1 second response time. 10 scans were collected and
averaged to enhance the signal to noise ratio. After subtracting the controls, spectra were
corrected for protein size (number of residues) and concentration to obtain the mean residue
molar ellipticity: [θ] (see Appendix A, CD). Experimental protein concentration was 5 mg/mL in
a 10 mM phosphate buffer (pH 7.4 at 25 °C).
Fluorescence quenching experiments Membrane insertion of Trp residues was
determined by fluorescence quenching spectroscopy, using the J-810 spectrofluoropolarimeter
described above. The samples were contained in a 4×4 mm2 rectangular quartz cuvette, with
constant stirring. Excitation and emission slits were 4 and 10 nm, respectively. Tryptophans were
selectively excited at 290 nm, and the emission spectra were recorded between 300 and 400 nm,
followed by spectral correction by subtracting the spectra measured under identical conditions
but without the protein or peptide. In experiments of Trp fluorescence quenching with
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acrylamide, PLA2 or peptide solutions were prepared in buffers that contained 1 mM EDTA, 50
mM HEPES (pH 7.4) and varying concentrations of acrylamide. Emission spectra were
measured, maximum fluorescence intensities without and with the quencher (F0 and F
respectively) were determined. In dual quenching experiments, Trp emission intensity was
measured in the presence of lipid vesicles with no quencher (F0), in the presence of vesicles and
with 250 mM acrylamide in the buffer (Facrly), and in the presence of vesicles containing 10
mol% of 10-doxylnonadecane (10DN) with no acrylamide in the buffer (F10DN).
Activity assay against bilayer membranes The activity of PLA2 toward LUVs was
assayed using a fluorescent substrate: 1,2,bis-(1-pyrenedecanoyl)-sn-glycero-3-phosphocholine
(BisPy-PC) that is labeled with two pyrene fluorophores, one at the end of each of the two acyl
chains. The two pyrenes in close proximity to each other emit a strong eximer (excited dimer)
signal at 470 nm, and the monomer profile has double maxima at ~380 and ~396 nm (Figure 8).

Figure 8 Bis Pyrene
Products of PLA2 hydrolysis and representative time dependent emission spectra. The initial
spectrum before the addition of enzyme is shown as a dotted line and spectra after the addition of
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enzyme as solid lines with decreasing intensity for later timepoints. Refer to the body of text as well
as appendix A:Bis-Py for further details.

The progress of phospholipid hydrolysis by PLA2 can be followed by the decrease in the
fluorescence intensity at 470 nm and the concurrent increase in the fluorescence intensity at 380
nm

81

. There is not a 1:1 correlation with the increase of monomer signal and concurrent

decrease in eximer signal, therefore, enzyme activity is graphically represented as a change in
Rt/R0 – 1 over time, where R is the ratio of fluorescence intensities at 380 and 470, and the
subscripts 0 and t refer to the ratio at initial and timepoint t, respectively. It should be noted that
the monomer to excimer ratio, R, is dependent not only on the total concentration of pyrene, but
also the variable half life of the excited-state (Molecular probes manual). The experimental
parameters were: 5 mol% of BisPy-PC incorporated into extruded vesicles, in a 50 mM HEPES
buffer (pH 7.5), 50 mM NaCl, 1 mM EGTA, 2.2 mM CaCl2. The composition of LUVs was
either 80:15 POPC:POPG or pure DPPC, at a final lipid concentration of 0.5 mM. An initial
spectra of the substrate was recorded, and the reaction initiated by the addition of enzyme.
Excitation wavelength was 347 nm and consecutive emission spectra were recorded between 370
and 490 nm.
Membrane binding measurements by FPE fluorescence This assay is based on the
sensitivity of FPE fluorescence to the ionization state of the carboxyl group of fluorescein such
that deprotonation increases the emission intensity. When the fluorescein moiety of FPE is
located at the interface of a negatively charged membrane, the interfacial environment is more
acidic than the bulk phase due to the electrostatic attraction of protons to the anionic membrane.
This causes a partial protonation of the carboxyl group of fluorescein, and an attenuation of
maximum fluorescence intensity. Adsorption of a cationic protein to the membrane locally
reduces the negative surface charge, increasing the emission intensity of proximal fluorescein
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moieties. Thus, binding affinity can be calculated from the change in fluorescence intensity,
brought about by this deprotonation of fluorescein, as a function of increasing protein
concentration

81; 85; 86

. Experimental parameters: 2 mol% FPE was incorporated into 100 nm

extruded LUVs composed of 58:40 POPC:POPG (40% PG). The total lipid concentration was
0.175 mM, suspended in 10 mM HEPES buffer (pH 7.4 at 25 °C), 1 mM NaN3, 1 mM EGTA in
a 0.4 cm cuvette, with 4 optically transparent faces. Excitation was at 490 nm, and emission
spectra were recorded between 500 and 540 nm, at 25 °C. Excitation and emission slits were 4
and 10 nm, respectively. After recording an initial spectrum of LUV in the buffer, 1 μL aliquots
of protein were successively added to the lipid suspension, equilibrated with constant stirring for
2 minutes, and spectra recorded for each protein concentration, [P]. Changes in the peak
fluorescence intensity, ΔF, were determined for each [P]. In control experiments, the lipid
suspension was diluted stepwise by 1 μL aliquots of buffer, in order to correct the values of ΔF
for the effect of dilution on the intensity of FPE emission. For details and comprehensive
equations pertaining to data analysis, see Appendix A: FPE.
Membrane binding measurements by RET Binding of the full-length hIB PLA2, the
hIB∆N10 fragment, and the N10-hIB peptide to vesicle membranes was measured by resonance
energy transfer (RET) from Trp (for full-length hIB PLA2 and N10-hIB peptide) or Tyr (for the
hIB∆N10 fragment) residues to Py-PE, which was present in membranes at 2 mol%. Vesicles,
composed of different proportions of POPC:POPG, were titrated into the protein solution, with
continuous stirring, to yield a total lipid concentration from 10 μM to ~1.0 mM. We used a low
salt buffer containing EDTA (10 mM HEPES pH 7.4, 1mM EDTA) to prevent lipid hydrolysis
during the experiment, and to avoid suppression of electrostatic protein-membrane interactions
by high salt concentrations. After each addition of vesicles, the sample was equilibrated for two
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minutes with stirring, and emission spectra were recorded. The concentration of N10-hIB peptide
and full-length hIB PLA2 was 4 µM while the hIB∆N10 fragment was used at 10 µM
concentration. The single tryptophan of the full-length hIB PLA2 or of the N10-hIB peptide was
excited at 290 nm and the tyrosines of hIB∆N10 fragment were excited at 275 nm. Parallel
control experiments have been conducted in which unlabeled vesicles (without Py-PE) were used
to titrate the protein solutions. In these control experiments, protein binding to the vesicles
resulted in an increase in the fluorescence emission intensity and/or a blue shift, whereas in RET
experiments with Py-PE-labeled vesicles, the emission intensity of the donor decreased and that
of the acceptor increased upon addition of vesicles due to energy transfer from Trp or Tyr to PyPE. Since RET results from short-range (typically 20-30 Å) dipole-dipole interactions between
the energy donor and the acceptor 87, detection of RET indicates binding of protein molecules to
vesicle membranes.
Tryptophan fluorescence quenching by acrylamide and 10DN Trp emission spectra
were measured in the absence or presence of varying concentrations of acrylamide, and
maximum fluorescence intensities were determined. The ratio of fluorescence intensities without
and with quencher (F0/F) was plotted against the acrylamide concentration. The slopes of the
best fit linear plots were used to determine the Stern-Volmer quenching constants (KSV). In dual
quenching experiments, Trp emission intensity was measured in the presence of lipid vesicles
with no quencher, in the presence of vesicles with 250 mM acrylamide in the buffer, and in the
presence of vesicles containing 10 mol% 10-doxylnonadecane (10DN) with no acrylamide in the
buffer, and the dual quenching ratio, RDQ, was determined (Appendix A:DQ). The quenching
experiments were performed in a buffer of 50 mM HEPES (pH 7.4) and 1 mM EDTA,
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containing 0.5 mM total lipid and 4 μM total protein. Excitation was at 290 nm, and temperature
was 25 °C.
Fluorescence quenching by brominated lipids Bromine (Br2), a natural quencher of
fluorescence emission, has been incorporated into the (6,7), (9,10) or (11,12) positions of 1palmitoy-2-stearoyl-(n,n+1)dibromo-sn-glycero-3-phosphocholine (Br2-PC). The distance of the
bromines from the membrane center, calibrated from X-ray diffraction experiments

88

are: 11.0,

8.3, and 6.5 Å for the (6-7), (9-10) or (11-12) Br2-PC respectively. These molecular rulers were
used to determine the depth of insertion of the tryptophan residues into the membrane.
Distribution analysis (DA) was employed to calculate depth from the quenching data (Appendix
A: DA). Experimental parameters: extruded vesicles composed of 25 mol% of Br2-PC, 25%
POPC and 50% POPG in 50 mM HEPES buffer (pH 7.4, at 25 °C), 1mM EGTA, 1 mM final
lipid concentration. Controls were 1:1 POPC:POPG LUVs without Br2-PC. The final protein
concentration was 0.4 μM. Excitation wavelength was 290 nm and emission spectra were
recorded between 300 and 400 nm.
Direct transmission FTIR and Attenuated Total Reflection FTIR Direct transmission
Fourier transform infrared spectroscopy (FTIR) and polarized attenuated total reflectance FTIR
(ATR-FTIR) experiments were carried out using a Vector 22 FTIR spectrometer (Bruker Optics,
Billerica, MA). For direct transmission experiments, the lyophilized protein was dissolved in a
D2O (deuterated water) based HEPES buffer and immediately assembled between two CaF2
windows, with a 25 μm spacer, and spectra were recorded at varying timepoints for 1 hour.
Spectra of proteins in H2O based HEPES buffer were collected using a 6 μm spacer. For ATR
experiments, a model 611 Langmuir-Blodgett trough (Nima, Coventry, UK) was used to deposit
a POPC monolayer on a germanium internal reflection plate (Spectral Systems, Irvington, NY).
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The plate was then assembled into an aluminum flow cell and sonicated vesicles, composed of
70:30 POPC:POPG (30% PG), were injected to form supported phospholipid bilayers. Excess
lipid was removed by gently flushing with H2O buffer. The protein, suspended in H2O based
HEPES buffer was then injected into the ATR cell and permitted to adsorb to the membrane for
~15 min, and spectra at parallel and perpendicular polarizations were recorded. The chamber was
gently flushed with 5 mLs of D2O-based buffer of the same composition and spectra were
collected at parallel and perpendicular polarizations for 1 hour. For both direct transmission and
ATR-FTIR, time zero was set at first exposure of the protein to D2O. All spectra were processed
and analyzed using Grams/AI V7 software suite (ThermoGalactic, Salem, NH). For second
derivative spectra, secondary structure evaluation and kinetics of hydrogen-deuterium exchange
(HDX), polarized spectra were first corrected in order to obtain polarization independent spectra
by spectral addition using the formula:
A = AII + 0.8A⊥
where the corrected absorbance, A, is the sum of the spectrum at parallel polarization and the
spectrum at perpendicular multiplied by a scaling factor, 0.8 in these experiments. Amide I and
amide II components were identified by curve-fitting using the number and positions of the
inverted second derivative peaks as peak centers, and relevant maximum and minimum values
for peak height and width parameters. The results of curve-fitting were considered satisfactory
when the peak frequencies of all components were within a ±1 cm-1 range of the input
frequencies, and when the sum of all components was coincident to the measured spectrum.
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CHAPTER THREE: RESULTS
Mutation, expression and purification of hIIA PLA2 PCR primer directed mutation of
the N1A hIIA PLA2 gene effectively yielded two mutants incorporating a tryptophan into the 3rd
and 5th positions, confirmed by DNA sequencing (data not shown). The modified expression
protocol yielded 30, 5 and 25 mg of protein per liter of bacteria culture for the hIIA PLA2, V3W
and F5W proteins respectively. The high yield enabled the calculation of the unique extinction
coefficient (ε280) for each protein from physical measurements. The resultant extinction
coefficients were 10,338 M-1 cm-1 for hIIA PLA2, 11,416 M-1 cm-1 for V3W, and 15,486 M-1 cm-1
for F5W. The two step purification by column chromatography yielded very pure protein
samples, which are required for structural analysis. Purity was confirmed by silver stained SDSPAGE, and specific activities determined using the Cayman sPLA2 activity kit. Only the highly
active fractions were pooled, dialyzed against pure water, lyophilized and stored at -80 °C. The
elution of hIIA PLA2 from the Superdex size exclusion column consistently ran as a double peak.
15% SDS-PAGE of the peak fractions revealed proteins of similar size, but markedly different
activities. The specific activities from the first peak fractions were negligible, but were
substantial in fractions from the second peak, corresponding to longer retention times. The
Superdex elution profile of a representative expression of hIIA PLA2, the corresponding silver
stained gel and specific activities of each elution fraction and. an overlay of representative
elution profiles of hIIA PLA2, V3W and F5W are shown in Figure 9. The V3W eluted with a
similar profile as the hIIA PLA2, only shifted toward longer retention times. The F5W mutation
eluted as a single broad peak around 85 mL, corresponding to the active fraction of the hIIA
PLA2, but demonstrated virtually no activity, therefore only fractions at the center of the peak
were pooled and lyophilized.
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Figure 9 Elution Profile
Additional purification by the Superdex size-exclusion column allowed us to produce highly pure and active PLA2 samples A) Representative
hIIA PLA2 elution profile, B) silver stained gel of the indicated peak fractions C) activity levels for the respective fractions and D) Overlay of
elution profiles for hIIA PLA2 (solid line), V3W (broken line) and F5W (dashed line)
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PLA2 activity against lipid micelles Comparison of the activities of hIIA PLA2, V3W,
F5W and hIB PLA2 toward DHTPC micelles indicated a four fold increase in activity for V3W as
compared to hIIA PLA2, and a complete loss of activity for F5W. The rate of the hIB PLA2 was
~35% of the hIIA PLA2 (Figure 10, Table 4). Enzymatic activities of the hIBΔN10 fragment and
the chimeric hIIA/IB PLA2 were also assayed using the same parameters. The activity of
hIBΔN10, was ~1% of hIB PLA2 (data not shown) and the activity of the chimeric hIIA/IB PLA2
was ~40% of the full-length hIB PLA2 (Figure 10B). The kinetic curves obtained with this assay
were linear over at least 10 minutes for all enzymes except V3W. The V3W curve indicates a
reduction in lipid hydrolysis as a result of substrate exhaustion, demonstrated by the resumption
of the high catalytic activity upon addition of fresh substrate (data not shown).
Although group I/II sPLA2s normally show little activity towards zwitterionic PC
membranes, they are active against DHTPC micelles because of their small radius of curvature.
The greater curvature is proposed to alleviate surface binding constraints and facilitate the transfer
of substrate from micelle to enzyme

89; 90

. The presence of BSA, a fatty acid ‘sink’ and the

conversion of the lysophospholipid in the liberation of the reporter eliminates any contribution to
enzyme activity by the build up of negative charge or possible disruption in the micellar surface.
In addition, because the concentration of substrate is much higher than the concentration of
enzyme, nearly complete binding of enzyme can be assumed. From the kinetic scheme (Figure 6)
we can assume that the parameters of this assay have been optimized in order to assess just the
catalytic activity of the enzyme. Therefore, the changes in catalytic rate for the V3W or F5W
mutant implies either i) a structural change disrupting the catalytic mechanism in the enzyme
brought about by the mutation, possible for the internal Trp5 but unlikely for the external Trp3; ii)
a change in substrate accessibility or binding to the active site by steric interactions, again a
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possibility for Trp5; or iii) a change in the mode of binding to the micelles, possible for either
enzyme as the tendency for tryptophan to sit at the lipid-water interface may initiate an
orientational difference between the binding of hIIA PLA2 and the Trp mutants to the micelles.

Figure 10 Activity against lipid micelles
A) Activity profile of hIIA PLA2 (solid line), V3W (broken line), F5W (dashed line), and hIB PLA2
(dotted line) final protein concentration was 0.35 μg/mL B) Relative activity of hIIA PLA2 (solid line),
hIB PLA2 (dotted line) and chimeric hIIA/IB PLA2 (dash dot) under the same assay conditions as in
(A), but with non standardized protein concentrations, therefore curves represent only the relative
activity of the chimeric to the parent enzymes.

The low activity of the hIBΔN10 fragment, which lacks the N-terminal helix, may result
from several factors also: i) loss of part of the substrate-binding pocket; ii) weaker membrane
binding; iii) improper orientation at the membrane surface; or iv) distortion of the structural
integrity of the molecule by breaking intramolecular H-bonding and nonpolar interactions. The
reduced activity of the chimeric hIIA/IB PLA2 compared to both the hIB PLA2 and hIIA PLA2
indicates that subtle changes in the sequence of the N-terminal helix have significant effect on the
enzyme behavior, which underscores the functional importance of the N-terminal helix of group
I/II PLA2s.
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Table 4 PLA2 catalytic activity
The specific activity as measured by the Cayman sPLA2 kit is presented in the first column as μmol per min per mg of enzyme. The activity
measured by BisPy-PC labeled vesicles is presented as a relative change, and is given as a change in absorbance over time.
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PLA2 activity against lipid bilayers The activities of hIIA PLA2, V3W, F5W and the full
length hIB PLA2, were also measured against large unilamellar vesicles (LUVs) labeled with 5
mol% of 1,2,bis-(1-pyrenedecanoyl)-sn-glycero-3-phosphocholine (BisPy-PC) in extruded
vesicles of pure DPPC, and also against extruded vesicles of 80:15 POPC:POPG (15% PG). The
concentration of anionic lipids is near the lower limit of noticeable activity for hIIA PLA2 (18%),
in order to separate the kinetic effects due to enhanced binding from the effects due to catalytic
efficiency. The hydrolysis of the sn-2 bond of the BisPy-PC labeled phospholipids effectively
separate the pyrene moieties at the respective ends of the sn-2 fatty acid and the sn-1
lysophospholipid. The hydrolysis was monitored by a reduction in the eximer signal at 470 nm
and a parallel increase in the monomer signal at 380 nm. As hIIA PLA2 did not demonstrate any
activity toward DPPC LUVs at 25 °C, (in the solid gel phase) for up to 1 hour following PLA2
addition (data not shown), the temperature was increased to 38 °C, close to the gel to liquidcrystal phase transition temperature of DPPC (Tm = 41.5 °C).
Under the conditions near Tm, the hIIA PLA2 demonstrated a complex kinetic profile,
showing a lag period of approximately 5 min, followed by ~10 minutes of intermediate activity,
then a burst of high activity at ~15 minutes. The kinetic profile for V3W showed a brief (2-3 min)
intermediate activity followed by very high activity, without a measurable lag time, however the
steady state activity was two times the steady state rate of hIIA PLA2. The hIB PLA2 had nearly
the same profile as V3W, but with a lag period for the first minute, and an intermediate activity
for ~1 min before a burst of activity. The steady state rate for hIB PLA2 was similar to V3W.
F5W demonstrated no activity in this assay. Qualitatively different results were obtained with
15% PG LUVs. In this case, hIIA PLA2 and hIB PLA2 had a 1.5 min lag phase, followed by a
moderate level of activity. V3W demonstrated very high activity immediately, without any
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apparent lag, to a level of ~30 times the maximum rate of hIIA PLA2, before resolving to a much
slower steady state rate.
Surprisingly, F5W showed a ~1.5 minute lag period and a subsequent moderate rate of
activity that continued to the end of the assay. The steady state for V3W, hIIA PLA2 and hIB
were approximately equivalent, with F5W at ~ 60% of hIIA PLA2. Figure 11 presents the kinetic
profiles of the three IIA enzymes and includes hIB PLA2 as a reference for the native Trp3 in two
conditions: against 100% DPPC at 38 °C and against 15% POPG vesicles at 25 °C. The relative
rates of activity for each of the rate transitions are presented in Table 4, as a change in absorbance
over time.

Figure 11 Activity against Lipid bilayers
Activity profiles: A) 100% DPPC at 38 °C and B) 15% POPG, 85% POPC. 2% Bis Pyrene PC was
incorporated into the extruded vesicles.

Our data are consistent with earlier findings describing interfacial activation: group hIIA
PLA2 shows no activity against PC membranes in the gel phase (T << Tm) but demonstrates
activity near Tm 71; 91; On zwitterionic (PC) membranes, the onset of high activity of hIIA PLA2

37

was preceded by a lag phase, which has been interpreted earlier to result from gradual
accumulation of the anionic reaction products in the membrane 71; 75; 91. The lag phase was shown
to become shorter and then disappear with increasing fractions of anionic lipids 75; 92. In a recently
published work, hIIA PLA2 preferentially hydrolyzed the liquid phase of a mixed phase substrate,
generating a localized increase in negative charge through product accumulation 93. All existing
data suggest that the burst of activity that follows the lag phase is a result of the recruitment of
more PLA2 molecules to the membrane. If the sole effect of the presence of Trp3 in the IBS of
V3W is enhanced binding to zwitterionic membranes, and the burst of activity is a result of more
enzyme binding, then the reduction or lack of lag phase can be attributed to a greater number of
V3W enzymes binding initially. However, Burack et al., 199592, demonstrated the bulk of a snake
venom group IIA PLA2 was “associated with the membrane at a time well before the abrupt
increase in catalytic rate”, revealing an inactive membrane bound state. Without quantitative
results demonstrating bound and unbound enzyme, binding can only be confirmed by the
presence of catalysis, but the absence of catalysis is not necessarily indicative of the lack of bound
enzyme. Nevertheless, the establishment of a steady state rate indicates an equilibrium between
bound and unbound states of PLA2. Therefore the steady state rate can be viewed as a measure of
specific activity alone, or a combination of the rate of binding of a single substrate to the active
site, the rate of catalysis, and the rate of product dissociation. The steady state rate for V3W was
approximately twice that of hIIA PLA2 on 100% DPPC (38 °C) or nearly identical on 15% PG. It
is interesting, that the steady state rate for the hIB PLA2 enzyme was slightly higher (1.7x) than
the V3W on 100% DPPC (38 °C), but was similar to V3W on 15% PG. It is also interesting to
note that the kinetic profile of V3W on 15% PG could be viewed as an inverse of a lag phase and
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subsequent burst of activity. In this light, the increase in product accumulation appears to reduce
the rate of activity of V3W to approximate that of the wild type enzyme.
The results presented here are in accord with that published earlier on the V3W mutant.
Neglecting the bias caused by aggregation, the earlier experimental results ascribe the changes in
binding affinity and activity of V3W 73; 74 to the affinity of tryptophan for membrane interfaces re:
V3W is active against aggregated zwitterionic substrate where hIIA PLA2 is not. The rates on
other substrates are inconsistent, resulting in ambiguity as to the exact nature of the change,
though what was extrapolated was a large increase in activity on low anionic substrates and a
modest increase or decrease on high anionic substrates, leading to the conclusion that there must
be a multiplicity of effects arising from electrostatic and hydrophobic forces.
As in the Cayman assay, the possible mechanism for the change in catalytic activity of
F5W could be i) a structural change caused by the introduction of Trp5 into the substrate binding
pocket; ii) interference in entrance of the phospholipid into the substrate-binding cleft because of
bulkier side chain of Trp5; or iii) a altered mode of membrane binding to the substrate caused by
the mutation.
Because binding to the aggregated substrate is the initial step leading to interfacial
activation, we will evaluate several aspects of membrane binding: the strength of membrane
binding, the mode of membrane binding, the depth of insertion into the membrane,
conformational changes induced by membrane binding and finally orientation of the bound
enzyme to the membrane.
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Strength of PLA2 membrane binding Obtaining an unambiguous dissociation constant
(KD) for membrane binding by hIIA PLA2 is problematic. The enzyme does not bind to
zwitterionic membranes, and conversely, the binding of anionic membranes is not only strong, but
the distribution of positively charged residues over the whole enzyme, not just across the IBS,
induces very large, multiple vesicle aggregates

94

. These aggregates promote light scattering,

strongly obstructing spectroscopic experiments in the UV region. For example, CD spectra of 0.8
mg/mL hIIA PLA2 with increasing concentrations of 1:1 diether POPC:POPG LUVs in phosphate
buffer, resulted in a strong reduction of protein signal by ≥1 mM lipid concentration (Figure 12).

Figure 12 Lipid aggregation effects
CD spectra of 0.8 mg/mL hIIA PLA2 with increasing concentrations of 50% di-ether
POPC:POPG. The initial spectrum before the addition of lipid is shown as a dotted line, and
subsequent spectra with increasing concentrations of lipids are shown as solid lines decreasing
in intensity, with the final spectrum as a broken line.

Vesicle aggregation can be minimized by different strategies, such as high ionic strength
buffer, membranes with moderate fraction of anionic lipids, or appropriate protein to lipid molar
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ratios. We have used membranes of 58:40 POPC:POPG, (40% PG) with 2 mol% of FPE, at
relatively low total lipid concentrations: 175 μM. The protein concentration was gradually
increased in increments that yielded measurable changes in the FPE fluorescence signal, yet did
not cause significant vesicle aggregation. Aggregation was monitored by the increase in light
scattering at right angle at 600 nm (data not shown).
The change in fluorescence was corrected for dilution effects and plotted as a function of
protein concentration. Using the formulation found in Appendix A: FPE, theoretical binding
isotherms were constructed and corresponding values for KD and N (the numbers of lipid
molecules per protein binding site) were derived, 81. See appendix A:FPE for further explanation
of N. Representative spectra demonstrating the increase in fluorescence due to protein binding,
the decrease in intensity due to dilution and the binding isotherms are presented in Figure 13.
The numerical parameters for KD and N, of hIIA PLA2, V3W, F5W, hIB PLA2 and the two
synthetic peptides, N10-hIIA and N10-hIB, as well as the chimeric hIIA/IB PLA2 determined by
FPE fluorescence are given in Table 5. Although this procedure yields slightly different values of
N for the three group IIA proteins, they are still within a reasonable range of 30-40 lipids per
membrane-bound PLA2 molecule, and are in good agreement with earlier data 81; 83; 95. The lack of
binding of hIIA PLA2 to zwitterionic membranes, and strong binding to anionic membranes are
indicative of a significant electrostatic component in PLA2-membrane interactions, consistent
with earlier data 74; 83; 94; 96; 97.
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Figure 13 FPE binding curves.
A) Representative spectra of the increase in fluorescence of FPE upon addition of protein. The initial
FPE emission spectrum before the addition of protein is represented by the dotted line, and subsequent
spectra by solid lines, increasing in intensity, the lightest having the lowest concentration of protein,
and the darkest, the highest. B) Dilution effects on fluorescence intensity, again lightest to darkest
intensity represents subsequent dilutions, with the darkest at the greatest dilution. C) Simulated
binding isotherms of the IIA proteins using the calculated KD and N values. Experimental data points
for hIIA PLA2 are represented as circles, for V3W as triangles and for F5W as squares.

Table 5 FPE Binding Parameters

Binding parameters KD and N determined by FPE labeled LUVs containing either 20 or 40
mol% of POPG, and the change in KD seen with the increase in anionic lipid (last column).

42

The dissociation constant of hIIA PLA2 for membranes containing 40% PG (KD = 0.3
μM), is in good agreement with earlier results obtained under similar conditions

81

. In other

studies, using different experimental approaches, e.g. sucrose-loaded vesicle centrifugation
method, 74 it is reported that hIIA PLA2 did not bind to PC or even to membranes of 82:18 PC:PS
(18% PS), but V3W did bind to 18% PS with a KD of 0.21 mM. On the other hand, using the
sucrose-loaded vesicle method, Bezzine et al., 2002

75

report a nearly 100-fold stronger binding

(in terms of KD) of the V3W mutant to 80:20 POPC:POPS membranes than hIIA PLA2 (KDV3W =
2.6 μM, KDhIIA = 230 μM). Where our data show only a 2-fold stronger binding affinity for
anionic membranes of V3W than hIIA PLA2, the anionic lipid in our study is POPG, the major
anionic lipid in bacterial membranes, a native substrate for the antimicrobial hIIA PLA2. Singer,
2002, 52 reports a preference of hIIA PLA2 for POPG over POPS, presented as a five fold increase
in specific activity toward phospholipid vesicles composed of a single type of lipid: PG or PS. In
spite of large quantitative differences in the absolute values of KD found in the collective hIIA
PLA2 data (a possible reflection of varying methods and experimental conditions as well as
aggregation effects), what is consistently reported, is an enhancement of membrane binding
toward zwitterionic vesicles upon introduction of a single, site specific tryptophan into the
interfacial binding surface of hIIA PLA2. Although there are no published data to compare with,
we report a weaker binding to anionic membranes of F5W than hIIA PLA2, and interpret the
impaired membrane binding in terms of structural perturbations upon interaction with the
interface.
Interestingly the KD for the chimeric hIIA/IB PLA2 was 1.8 μM, indicative of weaker
binding. The weaker binding could be the sole cause of the lower activity of the chimeric protein
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against micelles, however does not rule out structural perturbations or orientational changes due
to the different membrane interacting residues
Binding of the hIB PLA2 the hIB N-terminal peptide (N10-hIB) and its truncated
hIBΔN10 fragment, to phospholipid vesicles was quantitatively measured by resonance energy
transfer (RET) analysis. Binding of these molecules to 100% zwitterionic membranes was weak
and difficult to measure reliably. Therefore, we used large unilamellar vesicles containing 20 or
40 mol% acidic lipid, POPG. These experiments are physiologically relevant because most
biological membranes contain acidic lipids within this range. Since human group IB PLA2 has a
single Trp at position 3, Trp fluorescence was used as RET donor in analyzing membrane binding
of the full-length hIB PLA2 and the N10-hIB peptide, whereas Tyr fluorescence was used in the
case of the hIBΔN10 fragment (the protein has nine tyrosines between positions 22 and 123). The
energy

acceptor

was

2

mol%

1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(1-

pyrenesulfonyl) (Py-PE) in vesicle membranes in all cases. Titration of protein solution by
increasing concentrations of unlabeled vesicles (without Py-PE) resulted in either one or both of
the two effects, i.e., an increase in the fluorescence emission intensity and a blue shift. However,
the protein fluorescence intensity decreased upon addition of vesicles containing 2 mol% Py-PE,
evidently due to energy transfer from Trp or Tyr residues of proteins to Py-PE in vesicle
membranes (data not shown). Because of the complex absorption profile of pyrene, this
fluorophore can be excited by UV radiation at 270-290 nm, which was used for Tyr or Trp
excitation. Therefore, we measured RET on the basis of a decrease in the emission intensity of the
energy donor (Tyr or Trp residues of proteins) and not the increase in the emission intensity of
pyrene. Since RET is based on short-range (20-30 Å) dipole-dipole interactions between energy
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donors and acceptors

87

, the observed effect reflects binding of protein molecules to vesicles

membranes.
After correction of the RET data for sample dilution and for increase of emission intensity
upon binding to unlabeled vesicles, binding isotherms were constructed (Figure 14) as described
in Qin et al., 2004 83. Analysis of the RET data yielded the dissociation constants (KD) and N, the
numbers of lipid molecules per protein binding site, which are presented in Table 6.

Figure 14 RET binding isotherms
Binding isotherms for hIB PLA2 (squares), hIBΔN10 fragment (triangles) and N10-IB
peptide (circles) on POPC/POPG vesicles containing A) 20% PG and B) 40% PG

These data indicate that the binding of the N10-hIB peptide to membranes is comparable
with that of the full-length hIB PLA2 protein, but the increase in the affinity of the peptide for
membranes with increasing fraction of the anionic lipid is steeper compared to the full-length hIB
PLA2. On the other hand, the hIBΔN10 fragment exhibited significantly lower affinity for
negatively charged membranes than the full-length hIB PLA2 and little dependence on the
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fraction of the anionic lipid in membranes. This indicates the N-terminal α-helix of hIB PLA2
contributes to the sensitivity of the enzyme to the negative surface charge of membranes.
Table 6 RET binding parameters

Determination of KD by RET, affinity increases with greater fraction of anionic lipids.

The total surface of the IBS of hIB PLA2 is roughly 1700 Å2, and the N-terminal helix of
hIB PLA2 provides four residues for the IBS, i.e. Trp3, Arg6, Lys7, and Lys10

60

. Using the

accessible areas of 255, 225 and 200 Å2 respectively for tryptophan, arginine and lysine

98

, and

assuming that the residues can provide at most half of their total accessible surface area for
interaction with membranes, we estimate that the maximum contribution of the four hIB Nterminal residues in the total area of IBS is 0.5(255 + 225 + 400)/1700 ≈ 0.26, i.e., roughly onefourth of the IBS area is provided by the residues of the hIB N-terminal α-helix. This estimate is
supported by the fact that the number of lipids per protein binding site is 36-37 for the full-length
hIB PLA2 and 8-9 for the N10-hIB peptide (Table 6). Thus, although removal of ~¼ of the IBS
impairs the membrane binding strength of the protein, the truncated hIBΔN10 fragment still
retains substantial affinity for the membrane surface but loses 99% of the enzymatic activity.
Apparently, besides the impaired membrane affinity there are other reasons for the dramatic
46

decrease in the activity of the hIBΔN10 fragment. One obvious reason is that out of six key
residues that form the substrate binding pocket of the enzyme (Val2, Phe5, Tyr22, Asn23, Leu31,
and Tyr69) 60, two residues (Val2 and Phe5) are absent in the hIBΔN10 fragment.
The quantitative differences seen between the results from the two separate binding assays
are due to the assay conditions, where RET is a straightforward assay, the measurement of the
energy transferred from a single Trp to pyrene, the FPE is more qualitative. The overall
conclusions that can be drawn from these two assays are: there are group specific differences in
binding affinity relative to anionic strength of the membrane; there are no significant differences
in the binding affinity of hIIA PLA2 upon either Trp3 or Trp5 mutation; and the N-terminal helix
enhances the strength of membrane binding.
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Mode of PLA2 membrane binding Because fluorescence spectra are sensitive to the degree
to which the fluorophores are exposed to the polar aqueous phase or are hidden in the protein
body, fluorescence spectroscopy can be used to assess the local microenvironments of selectively
excited fluorophores within the global tertiary structure of proteins

87

. Tryptophan fluorescence

emission spectra of V3W, F5W and hIB PLA2 in solution are presented in Figure 15. As the hIIA
PLA2 does not contain tryptophan, it is not included here. The data obtained from the IB PLA2
isoform is used as a reference for the native Trp3.

Figure 15 Tryptophan Fluorescence
Tryptophan fluorescence emission spectra of V3W (dashed-double-dotted line), F5W
(dashed line) and hIB PLA2 (solid line) in 50 mM HEPES buffer, pH7.4 with 1mM EDTA.

The Trp emission peak was 347, 331, and 342 for V3W, F5W and hIB PLA2, respectively.
Lower peak wavelengths correspond to limited exposure of the fluorophores to water and weaker
solvent relaxation, resulting in greater emission energies, or frequencies (E = hν). The blueshift
of F5W therefore indicates the Trp5 is in a more protected environment than the V3W or hIB
Trp3, as expected because of its location in the substrate binding pocket. The ~5 nm difference
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between the V3W Trp3 and the hIB Trp3 indicates a slightly different microenvironment for the
two Trp3 residues. Though both are exposed to solvent, the 5 nm higher wavelength of the Trp3 of
V3W compared to that of the hIB PLA2 may indicate a more flexible structure of the V3W Trp3
or a more extensive contact with water.
Trp fluorescence quenching experiments on V3W and F5W with increasing
concentrations of the water soluble quencher, acrylamide, were performed in the presence and
absence of 1:1 POPC:POPG vesicles (50% PG). Stern-Volmer plots, depicting F0/F as a function
of acrylamide concentration, were generated, and the slopes of the best-fit linear plots have been
used to determine the Stern-Volmer quenching constants, KSV (Figure 16).

Figure 16 Acrylamide quenching
Stern-Volmer plots of Trp fluorescence quenching by acrylamide of V3W (left) and F5W (right) in
the absence or presence of POPC/POPG vesicles. F0 and F are maximum fluorescence emission
intensities without and with the quencher, respectively. F0/F decreases with the addition of lipids,
indicating a reduction in quenching efficiency as Trp3 is shielded from the aqueous quencher.

The plots demonstrate that both the Trp3 and Trp5 fluorescence decreases in a
concentration dependent manner with the addition of acrylamide, both in the absence and
presence of vesicles containing 50% POPG. The reduction in quenching efficiency in the
presence of vesicles indicates an insertion of the Trp residues into the membrane, consequently
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becoming partially protected from the effects of acrylamide quenching. The implication of the
membrane insertion of Trp5 is addressed below (depth of insertion results).
Fluorescence spectra of hIB PLA2 and the N10-hIB peptide were also measured in the absence
and presence of lipid vesicles composed of either pure POPC, pure POPG or with 25, 50, or 75
mol% of POPG (Figure 17). In the presence of pure zwitterionic POPC vesicles, there was little
change in the peak position of hIB Trp3 fluorescence from the peak position in the presence of
acrylamide alone, confirming that hIB PLA2 does not bind appreciably to zwitterionic
membranes. With increasing proportions of POPG however, the peak fluorescence wavelength
(λmax) decreased in a sigmoidal manner, with a max change of ~10nm in the presence of vesicles
composed of 100% POPG. The blueshift (decrease in wavelength) of the λmax is indicative of the
microenvironment of the hIB Trp3 changing from a polar aqueous phase, to a less polar
environment such as a dehydrated protein-membrane interface, or hydrophobic membrane.

Figure 17 Fluorescence spectra of hIB PLA2
A: Fluorescence spectra of hIB PLA2 in the absence (dotted line, which can be hardly discerned
because of overlap with the dark solid line) and presence of POPC:POPG lipid vesicles composed
of 0.0, 25, 50, 75, and 100 mol% POPG (solid lines changing from dark to light). B: Dependence
of the peak wavelength (λmax) of Trp3 fluorescence spectra of hIB PLA2 (squares) and the N10-hIB
peptide (circles) on the fraction of POPG in membranes. The data points to the left of zero fraction
POPG correspond to the Trp3 emission spectra in the absence of lipid (in solution).
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The λmax for the N10-hIB peptide also decreased a total of ~10 nm as the proportion of POPG
within the vesicles increased, but unlike hIB PLA2 the λmax of the peptide Trp3 in solution was
higher than the λmax in the presence of vesicles. The peptide also demonstrated a slight shift upon
binding to 100% POPC vesicles and reached the maximum blueshift at 50% POPG. The higher
λmax for the peptide Trp3 in the presence (~353 nm) or absence (~343 nm) of vesicles indicates a
more polar microenvironment for the identical Trp3 without the bulk of the enzyme. Stern-Volmer
plots were also generated for the full length and N10-hIB peptide Trp3 acrylamide quenching and
KSV obtained (Figure 18).

Figure 18 Acrylamide Quenching
Quenching of Trp fluorescence of hIB PLA2 (A) and the N10-hIB peptide (B) by acrylamide in the
absence of lipid (circles) or in the presence of 100% POPC (squares), 25% (triangles), 50% (inverse
triangles), 75% (rhombs), and 100% POPG (crosses) vesicles. (C) Plots of KSV as a function of the
fraction of POPG in POPC/POPG membranes, for hIB PLA2 (squares) and the N10-hIB peptide
(circles). The data points to the left of zero fraction POPG correspond to the values obtained in the
absence of lipid.

Stern-Volmer constants (KSV, an indicator of the efficiency of fluorescence quenching), were
obtained from the four Stern-Volmer plots (Appendix A: DQ), and are presented in Table 7. The
KSV for the V3W, hIB PLA2 and the N10-hIB peptide Trp3 free in solution was 12.6, 9.0 and 16.6
M-1, respectively and decreased to 2.2, 1.9 and 3.1 M-1 in the presence of vesicles containing 50%
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POPG. These results indicate that with increasing membrane anionic surface charge the Trp3,
which is a part of IBS of group IB PLA2s, becomes less accessible to water-soluble acrylamide.
The KSV for the F5W Trp3 in solution was 3.2 M-1, reflecting the position of the residue within the
enzyme, and was reduced to 1.4 M-1, in the presence of 50% PG vesicles indicating an increased
shielding effect by the association of the enzyme with the membrane.
Dual quenching experiments in the presence of vesicles containing 50% POPG and either the
water-soluble acrylamide (250 mM in the buffer), or the membrane-soluble 10DN (10 mol% in
the membranes) were performed (Figure 19). The significant increase in Trp fluorescence
intensity in the presence of phospholipid vesicles, accompanied by a blue shift in the fluorescence
peak positions of V3W, hIB PLA2 and N10-hIB peptide is an indicator of efficient membrane
binding.
The dual quenching ratios (RDQ), comparing the efficiency of acrylamide quenching to
10DN, were determined (Appendix A: DQ). The RDQ values were 0.78, 0.60 and 0.69 for V3W,
hIB PLA2 and the N10-hIB peptide, respectively (Table 7). These RDQ values reflect a
significantly stronger quenching of Trp3 by the membrane soluble quencher than by acrylamide,
indicating an effective insertion of the three different Trp3 residues into the hydrophobic core of
the membrane. Conversely, the RDQ value for the F5W Trp5 residue was 1.1, reflecting similar
quenching by acrylamide than 10DN.
These results demonstrate the intimate contact of the enzyme upon membrane binding
resulting from the insertion of Trp3 into the membrane.
quenching method to determine the depth of insertion.
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We employ another fluorescence

Figure 19 Dual Quenching
(A) hIB PLA2, (B) N10-hIB peptide (C) V3W (D) F5W. Solid lines are free in solution,
dotted lines are in the presence of vesicles composed of 50% PG, dashed lines are 50% PG
vesicles with 10DN, and dash dot lines are in the presence of 50% PG vesicles and
acrylamide.
Table 7 KSV and RDQ

Values of KSV , the measure of acrylamide quenching efficiency and RDQ , the ratio of
quenching efficiencies of acrylamide and 10DN on tryptophan fluorescence in solution and
in the presence of 100% POPC, 100% POPG and 50% POPG vesicles.
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Depth of PLA2 membrane insertion There is emerging evidence that not only the
strength of membrane binding, but also the precise mode of membrane binding, including the
angular orientation and the depth of insertion, are important determinants of the function of
peripheral membrane proteins 81; 82; 99; 100; 101; 102; 103. On the other hand, partial membrane insertion
of PLA2 during interfacial activation is still a matter of debate. We have measured the depth of
Trp insertion into LUVs containing 50% anionic lipids for V3W, F5W (Figure 20) and hIB PLA2
(not shown).
Depth was measured as a function of quenching of the intrinsic fluorescence of tryptophan
by bromine labeled lipids (Figure 21A), and maximum average depth was determined by
distribution analysis (Appendix A: DA). The parameters used to determine the depth of
tryptophan are given in Figure 21 B. These results show the V3W Trp3 inserts into the membrane
approximately 9.5 Å from the membrane center, similar to 9.1 Å for the hIB PLA2. The results
also show the insertion of the hIIA Trp5 residue into 50% anionic membrane to a similar depth as
the IB.

Figure 20 Depth of Tryptophan insertion
A) V3W and B) F5W in solution (solid line) and in the absence (dotted line) and presence of
bromine labeled lipids. Br 6-7 dash-dotdot line, Br 9-10 dash-dot line and Br11-12 dashed lines.
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Figure 21 Brominated lipids.
A) Lipids labeled at the 6-7, 9-10 and 11-12 positions with bromine B) DA parameters for V3W,
F5W, hIB PLA2, and bee venom (bv PLA2), acting as a negative control; hm (Å) = mean distance
from the membrane center. σ = positional distribution between the fluorophore and quencher, larger
values indicate a broader depth distribution, more variation in depth. S = area under distribution
curve, it is a function of the efficiency of quenching: a smaller value (less efficiency) indicates a
restricted accessibility of the quencher to the fluorophore.

The hIIA PLA2 residues Leu2, Val3, His6, Arg7 and Lys10 have been shown to interact with
the membrane. Ile9 and Phe5 have both been implicated in substrate binding to the enzyme, inside
the binding cleft. Therefore the Trp5 would have to rotate by at least ~30° in order to interact with
the membrane (Figure 7), either by distortion of the first 4 N-terminal residues, or by a twisting
and disruption of the entire N-terminal helix, which is unlikely, considering the strength of
hydrogen bonding within an alpha helical structure.
However, the mobility of the N-terminal helix en bloc has been demonstrated 104. In the Xray crystal structures of unbound and substrate-mimic bound hIIA PLA2, the translational
movement of the entire N-terminal helix by approximately 1Å is clearly seen. In addition, the
results from the acrylamide quenching assay (Figure 16) indicate some accessibility of the Trp5 to
acrylamide when the enzyme is in solution. The steric interaction by the larger Trp5 could
possibly repel the N-terminal helix around the helical axis enough to allow the interaction of Trp5
with the membrane. The presence of a glycine at position 14 (proline in IB enzymes), would
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allow this type of rotation (see Figure 3). The conformational disturbance of the alpha helical
structure would then be minimized by the orientation of the entire helix toward the membrane.
This work provides evidence that structurally similar group hIB and hIIA PLA2s,
significantly penetrate into membranes.
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PLA2 Conformational changes upon membrane binding: CD In order to evaluate the
secondary structure of the PLA2 enzymes, far-UV CD spectra of were measured and compared.
Circular dichroism allows the qualitative evaluation of secondary structures of molecules. Alpha
helix, beta sheet, beta turn, and unordered structures have well defined CD ‘fingerprints’ (Figure
22).

Figure 22 Characteristic CD Spectra
Alpha helix (solid), Beta sheet (dashed), Beta turn (dash dot dot) and unordered structures (dotted line).

The CD spectra for the hIIA PLA2 proteins (Figure 23) exhibit a classical alpha helical
profile, with two minima at ~208 and ~222 nm, and a single maximum at ~192 nm. The general
similarities of the V3W and F5W to the hIIA PLA2 spectra indicate that neither mutation
significantly perturbed the secondary structure of the protein. Similar results were reported by
Baker et al., 1998 73 for the V3W mutation.
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Figure 23 CD spectra of hIIA PLA2, V3W, F5W, and hIB PLA2.
Spectra were recorded in 10 mM phosphate buffer, pH 7.4, at a final protein concentration of
5 mg/mL in a 0.2 cm pathlength cuvette.

It is possible, in light of the above results, that the substitution of a bulkier, more polar Trp
on the hydrophobic face of the amphipathic N-terminal helix, which forms one wall of the
substrate binding pocket, has perturbed the helical structure of F5W. The slightly higher ellipticity
ratio would then be due to the perturbation of a standard a helix conformation. hIB PLA2 also
demonstrates a greater shift in ellipticity ratio ([θ]222/ [θ]208) of 1.1, probably due to a difference
in the overall content of alpha helices between the IIA PLA2 and IB PLA2 isoforms. Structural
analysis from NMR experiments on porcine group IB PLA2 show the first three residues of the Nterminal helix are disordered in solution

105

, but upon binding to substrate micelles, the three N-

terminal residues conform to a rigid α-helix 80. Since porcine IB PLA2 free in solution has a less
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ordered N-terminal helix than the snake venom IIA PLA2 68, hIB PLA2 may be expected to have a
higher value of the [θ]222 / [θ]208 ratio than hIIA PLA2, as detected.
The CD spectra for hIB PLA2 and its IBΔN10 fragment are shown in Figure 24. The two
proteins also exhibited an alpha helical profile with a double minima around 223 and 209 nm in
the spectra of hIB PLA2 and the hIBΔN10 fragment. The helicity of the full-length hIB PLA2
slightly decreased whereas that of the hIBΔN10 fragment increased in the presence of
phospholipid vesicles, the former of which is consistent with NMR data on porcine IB PLA2 in
the absence and presence of phospholipid micelles 69; 80; 106. The CD spectra of the full-length hIB
PLA2 and the hIBΔN10 fragment exhibited significantly different line-shapes.

Figure 24 hIB PLA2 CD spectra
CD spectra of A) hIB PLA2 with and without lipid B) its hIBΔN10 fragment with and without lipid
and C) the N10-hIB peptide in the presence of increasing concentrations of lipid. For A and B: the
solid lines are protein in buffer and the dotted lines are in the presence of nonhydrolyzable ether lipid
vesicles di-O-tetradecyl-phosphatidylcholine/di-O-tetradecyl-phosphatidylglycerol at 1:1 molar ratio
(1 mM total lipid) 10 μM final protein concentration. C: Lightest curve is the peptide in buffer,
Spectra of the N10-hIB peptide in presence of 50% TFE (vol:vol) is shown as a dotted line.

The ellipticity ratio was 1.1 for the full-length hIB PLA2 and 0.87 for the hIBΔN10
fragment free in solution. The ellipticity ratio [θ]223 /[θ]209 is known to increase with increasing
flexibility of the helices 107; 108. Therefore, the difference between the profiles of the CD spectra of
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the full-length hIB PLA2 and the hIBΔN10 fragment may indicate increased flexibility of the fulllength hIB PLA2 compared to the hIBΔN10 fragment. A decreased flexibility of hIB PLA2 upon
removal of the N-terminal 10 residues would predict that the separated N-terminus of the protein
in aqueous buffer is likely to be flexible. Indeed, the spectrum of the synthetic N10-hIB peptide in
aqueous buffer was characterized by a single minimum around 200 nm, (Figure 24 C) indicating
unordered structure for the N10-hIB peptide

109; 110; 111; 112

. The presence of negatively charged

lipid vesicles induced increasing fractions of α-helix in the peptide, which probably results from
the stabilization of the α-helical conformation by electrostatic interactions between the cationic
residues at one face of this amphipathic helix and the acidic lipids. NMR and X-ray studies have
shown that the α-helical structure of the N-terminus of porcine pancreatic PLA2 is additionally
stabilized by hydrophobic interactions between the nonpolar face of the helix and bound inhibitor
or substrate molecules 69; 76; 106.
The CD spectrum of the hIIA/IB PLA2 chimera demonstrated the characteristic alpha
helical double minima around 208 and 222 nm, with an absolute value of the mean-residue molar
ellipticity at 222 nm ([θ]222) comparable to those measured for group IB and IIA PLA2s (Figure
25). This indicates that the chimeric protein is folded into a structure that comprises ~40% αhelix, which is characteristic of group I/II PLA2s

113; 114

. The shape of the CD spectrum of the

chimeric protein was different from those of the group IB and IIA PLA2s, however. The CD
spectrum of the IIA/IB PLA2 chimera exhibited an decreased ellipticity ratio [θ]222/[θ]208 as
compared to both hIB PLA2 and hIIA PLA2. Reduced values of the ellipticity ratio [θ]208/[θ]222
are associated with deviations of the α-helix structure from a standard, rigid helix geometry, e.g.
by formation of coiled-coil structures 107; 108 or distorted helices 115. Although the two internal αhelices of group I/II PLA2s (H2, H3) are nearly antiparallel and disulfide-bonded, they are not
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likely to form a coiled-coil structure. The observed feature is therefore more likely to indicate a
less flexible conformation of the chimeric hIIA/IB PLA2 compared to the hIB or hIIA PLA2
proteins.
Though no major perturbations in structure are seen with these results, the proposed
qualitative differences can be more closely examined by FTIR spectroscopy.

Figure 25 CD of hIIA/IB chimera

CD spectra comparing the chimeric hIIA/IB PLA2 to the parent enzymes. hIIA PLA2
(dashed line), hIB PLA2 (dotted line) and hIIA/IB PLA2 chimera (solid line).
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PLA2 Conformational changes upon membrane binding: FTIR The quality and
quantity of a protein’s secondary structure can be extrapolated from careful evaluation of the
amide I absorbance spectra obtained from Fourier transform infrared (FTIR) spectroscopy. The
protein backbone atoms that constitute a peptide unit are involved in various complex vibrational
modes known as amide modes. Of special interest are the amide I mode and amide II modes
1600-1700 cm-1 and 1560-1545 cm-1, respectively (Figure 26).

Figure 26 ATR-FTIR absorbance bands
Representative spectrum of a membrane bound protein, the lipid methelene stretch is seen at ~2800-2900,
the protein amide I region is between 1700 - 1600 cm-1 and the amide II region centers around 1545 cm-1.

By convention, FTIR spectroscopy uses the spatial frequency. i.e., the wavenumber (W) in
dimension of cm-1, which is the inverse of the wavelength (λ), W = 1/λ, rather than the temporal
frequency (ν) in dimension of s-1. There is a simple relationship between them: ν = c/λ = cW,
where c is the velocity of light. The amide I mode is mostly comprised of the protein backbone
C=O stretching vibration and is very sensitive to the protein secondary structure. The range of
amide I absorbance frequencies for secondary structural elements have been well characterized 116
and are presented in Table 8 and Figure 28.
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Table 8 Amide I peak frequencies

Amide I Peak frequency range (in D2O) and correspondent secondary structure components.

Figure 27 Sample amide I curve fit
Representative amide I peak assignments for secondary structure absorbance bands. The
experimental spectrum, (light grey) is deconvolved using the corresponding peaks in the inverted
second derivative spectra (solid line bottom). The resultant curve fit, a summation of the
individual bands, is superimposed over the experimental curve. The correctness of the fit is
demonstrated by the tight correspondence of the two lines.
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Deuterated water (D2O) is the solvent typically used in FTIR experiments for protein
secondary structure determination, as the H-O-H bending vibrational mode of water absorbs
around 1643 cm-1 and can eclipse the Amide I spectra, which can confound the deconvolution of
the Amide I peak unless very high protein concentrations are used. The larger mass of deuterium
in D2O shifts the bending vibration of the D2O to a lower frequency, resulting in a solventunimpeded Amide I spectra. The amide II mode involves a large contribution from the N-H
bending mode and is sensitive to amide hydrogen-deuterium exchange as solvent exposed N-H
groups exchange quickly with the D2O to become N-D (see below, results of HDX kinetics).
ATR-FTIR spectroscopy is uniquely suited for evaluating membrane associated proteins
within the unique environment of the membrane-water interface. Unlike the higher resolution
techniques of NMR and X-ray crystallography, the qualitative and quantitative structure of the
protein in the context of membrane (binding or insertion) can be obtained. The presence of the
supported bilayer not only provides the appropriate physiological condition, the nature of ATRFTIR enables the visualization of only those molecules directly associated with the membrane.
Any unbound molecules in the solvent are not within the detection limits of the system, therefore
any ambiguity that may arise from a heterogenous population are eliminated.
The Curve fitting results for hIIA PLA2, V3W and F5W proteins, free in solution and bound
to 30:70 POPG:POPC (30% PG) supported bilayers, are presented in Figure 28, the frequencies
of the secondary structure components are presented in Table 9, and the proportions of alpha, beta
and unordered structures are presented in Table 10.
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Figure 28 Peak deconvolution
Secondary structure peak fitting of the amide I band for hIIA PLA2 (left), V3W (center) and F5W (right), free in solution (top) and
membrane bound (bottom). The alpha helical peaks are centered around 1650 – 1660 cm-1 and the peaks representing beta structures are
centered around 1635 cm-1. The second derivative spectra, from which the peak center frequencies were obtained is superimposed across
the center of the spectra. The splitting of the individual bands can be clearly seen in the second derivative spectra of the proteins that are
free in solution (top row).
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Table 9 hIIA PLA2 FTIR curve fitting results

Amide I component peak frequencies (ν, cm-1) and fraction of amide I band (%) for hIIA PLA2, V3W and F5W in two conditions.

66

Table 10 Proportions of secondary structures

Top: free in solution, bottom: membrane bound; hIIA PLA2 (left), V3W (center) and F5W
(right). Compositions for the structural elements correlate with previous values obtained
using higher resolution methods for determining tertiary structure showing ~40% alpha
helix, ~10% beta sheet and ~50% unordered structure, turns and loops.

The data indicate two components in the alpha helical region for all three proteins free in
solution, located at 1655-1658 cm-1 and 1650-1648 cm-1, which can be ascribed to unexchanged
and deuterated alpha helices, respectively. This assignment results in 41- 47% alpha helix for
hIIA PLA2 and V3W, in agreement with high resolution structures of group IIA PLA2s

104; 117

.

The data do not indicate major conformational changes caused by the Trp3 substitution, which
agrees with the CD data (Figure 23). For membrane bound hIIA PLA2 and V3W, the higher
frequency alpha helical component shifts to ~1661 cm-1, while the other component undergoes
little spectral shift. This may reflect structural destabilization of a fraction of alpha helices during
membrane binding, resulting in weaker helical hydrogen bonding, stronger backbone carbonyl
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bonds, and increased amide I frequencies, as detected earlier for a snake venom group IIA PLA2
118; 119

. In the case of hIIA PLA2, the alpha helical content appears to decrease slightly upon

membrane binding, consistent with weaker helices in the membrane bound state, while no such
changes are observed for V3W.
Curve fitting of the amide I bands of the F5W yielded qualitatively different results. For
both free in solution and membrane-bound F5W, two components were found in the
conventional alpha helical region, one around 1658 cm-1, and the other in the 1652-1648 cm-1
region, which are likely to represent the alpha helices with unexchanged and deuterated
backbone amide groups. For F5W free in solution, these components constitute 42.5% of the
amide I band, which is similar to the helical content for the free in solution hIIA PLA2 and V3W,
implying that neither Trp3 nor Trp5 substitutions cause significant changes in the protein
backbone structure. However, for the membrane-bound F5W mutant these two alpha helical
components constitute only 28% of the amide I band intensity, ~14% less than in the protein free
in solution. Interestingly, the fraction of components in the 1636-1626 cm-1 concomitantly
increases by 15% upon membrane binding of the F5W mutant (Table 9). One presumptive
interpretation of this result might be a conversion of ~18-19 residues of the protein (15% of 124
residues) from alpha helical conformation to beta structure. However, given the robust three
dimensional structure of secretory PLA2s stabilized by multiple disulfides, this is very unlikely to
occur. Again, in light of the depth dependent quenching assay, a reasonable interpretation of the
amide I curve-fitting results is: upon membrane binding the Trp5 inserts into the membrane and
the interaction with the other two helices is destabilized. The amide I component of the
membrane bound F5W at 1664 cm-1 may then be attributed to an αII-type flexible helical
structure 120 that absorbs in this infrared region 121; 122; 123. In this case, the total helical content of
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the membrane-bound F5W mutant, found in three alpha helical components, would constitute
39.4%, only 3% (~4 residues) less than the helical structure in the free protein. Combined with
the depth dependent quenching and CD results, it would seem that the Trp5 of the F5W, located
on the hydrophobic substrate binding face of the N-terminal helix, interacts with the membrane
and thereby causes a structural distortion of the N-terminal helix of the protein upon membrane
binding.
In light of these results, the decreased activity of F5W may be determined not by
blockage of the substrate entrance into the active site slot, but by a distorted N-terminal helix,
which is known to be an indispensable part for PLA2 activity 83. The fact that the activity of F5W
against zwitterionic phospholipid micelles or vesicles is almost completely lost, but significant
activity against anionic membranes is retained, probably results from different modes of binding
of the protein to curved interfaces. On micelles, interactions of Trp5 with the surface is likely to
predominate in affecting the mode of binding, while on LUVs, the electrostatic interactions
between the cationic residues surrounding the IBS and the anionic membrane predominate,
causing the enzyme to adopt a more appropriate mode of membrane binding and enabling access
of the substrate to the catalytic site.
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PLA2 Conformational changes upon membrane binding: HDX One of the most
powerful methods of probing protein dynamic structure is based on the analysis of amide
hydrogen-deuterium exchange (HDX) kinetics, which can be measured by FTIR spectroscopy
116; 124

. The amide II band (Figure 26), which involves a major contribution from the amide N-H

in-plane bending mode, shifts from ~1545 to 1450 cm-1 upon amide deuteration, resulting in a
time dependent decrease in the intensity of the band around 1545 cm-1. Each peptide unit in the
protein has a unique amide exchange rate, a function of solvent exposure, intramolecular Hbonding, local sequence and microenvironment. Ideally the HDX of a protein of nres amino acid
residues should be described using nres -1 rate constants. Although the multiexponential decay of
the amide II intensity could be described by a large number of decay (rate) constants, this would
not be a feasible approach, as the reliability of their values strongly decreases with increasing
numbers of fitting parameters. Alternately, fitting the HDX kinetics with only three populations
of amino acid residues: exchange resistant, slow exchanging, and fast exchanging populations,
has been shown to be a reasonable approach, in most cases the fractions and rate constants of
these populations can be determined reliably 116; 124.
The kinetics of HDX was determined based on the time-dependent decrease in the amide
II band intensity around 1545 cm-1 (Appendix A: HDX). We have used this approach to
characterize the membrane binding induced changes in the dynamic structure of the three hIIA
PLA2 proteins, presented in Figure 29. The numerical parameters for the three populations are
summarized in Table 11.
The data clearly indicate an increase in the HDX efficiency of all three molecules upon
membrane binding, resulting in a 5-10% decrease in the fraction of exchange resistant residues
(a0). However, the dynamic conformational changes of F5W are different from hIIA PLA2 and
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V3W. For the latter two proteins, membrane binding results in an increase in slow exchanging
residues (a1), and a decrease in fast exchanging residues (a2), with an increase in the rate
constants of both slow (k1) and fast exchanging residues (k2). The decrease in a0 and an overall
increase in rate constants of HDX can be interpreted in a straightforward manner, in terms of an
increased motional flexibility of a proportion of alpha helices in the membrane-bound hIIA PLA2
and V3W, consistent with the conclusion derived from the amide I curve-fitting data (Table 9).

Figure 29 hIIA PLA2 Hydrogen Deuterium kinetics
Top: (left) Representative spectra of hIIA PLA2 in H2O (solid line) and one hour post deuteration
(dotted line) illustrating the change in the amide II intensity upon deuteration; and (right) kinetic
curves for hIIA PLA2; bottom: (left) V3W and (right) F5W. Timepoints for enzyme free in solution
are closed circles and for membrane bound are open circles.
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Table 11 Hydrogen deuterium exchange kinetics

HDX parameters for hIIA PLA2 (left), V3W (center) and F5W (right); free in solution (top) and
membrane bound (bottom). a0 are the exchange resistant; a1 the slow exchange and a2 the fast
exchange populations of amide hydrogens; k1 and k2 are the rate constants (min-1) for a1 and a2
respectively.

The increase in the fraction of slow exchanging residues (a1), which is largely
compensated by a decrease in the fraction of fast exchanging residues (a2), most likely results
from the seclusion of residues in the dehydrated protein-membrane interface, effectively
shielding them from the solvent (note that the D2O buffer was injected subsequent to protein
binding to the supported membrane in an H2O buffer).
The 13-14% decrease in fast exchanging residues (a2) upon membrane binding translates
to ~17 amino acid residues that undergo fast HDX in the free protein, but become less accessible
to the solvent upon membrane binding. Using an average accessible surface area of 200 Å2 for
amino acids 98, and assuming that nearly half of this area contributes to the protein surface area,
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we obtain ~1700 Å2 for 17 protected residues on the membrane binding face of PLA2, in good
agreement with previous estimates of the total area of IBS 60.
Data of the kinetics of amide HDX clearly show that the dynamic behavior of F5W is
different from hIIA PLA2 and V3W. For hIIA PLA2 and V3W, the fraction of fast exchanging
residues decreases and that of the slow exchanging residues increases upon membrane binding,
whereas membrane binding of F5W results in changes in these populations to an opposite
direction. On the other hand, the rate constants (k1, k2) of all three proteins increased during
binding. The substantial increase in the fraction of the fast exchanging residues (a2), during
membrane binding of the F5W is in sharp contrast to the decrease in the fast exchanging residues
(a2) for the other two proteins. From the absence of dramatic differences in membrane binding
constants (KD) of all three proteins (Table 5), it can be inferred that the conformational
destabilization, seen in the above results for membrane-bound F5W (Figure 29 and Table 11), is
probably significant enough to substantially increase the number of residues that rapidly undergo
HDX, even with the partial protection of IBS residues from the solvent. The loss of activity on
micelles and the reduced activity on LUVs by F5W can now be attributed to the distortion
caused by the interaction of Trp5 with the aggregated substrate upon binding. However, we have
yet to define the large change in catalytic rate observed with the Trp3 substitution.
The kinetics of amide HDX of the full-length hIB PLA2 and its hIBΔN10 fragment, free
in solution and bound to supported membranes, were also determined (Figure 30). Analysis of
the HDX kinetics of the full-length hIB PLA2 free in solution showed that a0 ≈ 2% of all residues
were exchange-resistant, a1 = 7% were exchanging with k1 ≈ 0.07 min-1, and a2 = 91% with k2 =
3.3 min-1. In sharp contrast to the behavior of hIIA PLA2 and its V3W mutant, membrane
binding of hIB PLA2 results in a decrease in amide HDX efficiency. The membrane-bound hIB
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PLA2 indicated an increase in the fractions of exchange-resistant and slow-exchanging residues
to ~7% and 13%, respectively, and a concomitant decrease in the fraction of fast exchanging
residues to 80%. There is a marked decrease in the efficiency of the amide HDX of hIB PLA2
upon membrane binding implying either a reduced solvent accessibility to the membrane-bound
protein or a stabilization of its secondary structure elements. The HDX data of both free and
membrane-bound hIBΔN10 fragment were described by the same set of parameters: the fraction
of exchange-resistant residues a0 ≈ 14%, a1 = 38% of residues exchange with k1 ≈ 0.44 min-1 and
a2 = 48% of residues exchange with k2 ≈ 0.48 min-1. Clearly, the hIBΔN10 fragment is more
resistant to amide HDX exchange and undergoes little changes in conformational dynamics upon
membrane binding compared to the full-length PLA2.

Figure 30 hIB PLA2 HDX kinetics
Kinetics of amide hydrogen/deuterium exchange of the full-length hIB PLA2 (A) and its hIBΔN10
fragment (B) free in buffer (open symbols) and membrane bound (closed symbols).

The major differences seen within the HDX results are between the dynamic nature of the
hIIA and hIB PLA2 isoforms. Where the dynamic structure of hIIA PLA2 becomes more flexible
upon membrane binding, the dynamic structure of hIB PLA2 is stabilized by membrane binding.
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PLA2 Orientation to the membrane surface: RATR In order to determine if the
difference in catalytic activity upon substitution of Val3 and Phe5 for Tryptophan in the hIIA
PLA2 involves an element of different modes of membrane binding, we have directly assessed
the orientations of the three membrane-bound hIIA PLA2 proteins by polarized ATR-FTIR
spectroscopy. In polarized ATR-FTIR experiments, bilayer membranes are being prepared at
both surfaces of an internal reflection plate, such as germanium, and absorbance spectra are
measured at two different plane-polarizations of the incoming infrared light, corresponding to the
electric vector of the light parallel and perpendicular to the plane of incidence. The light enters
the plate at a set angle (45° in these experiments) and travels inside the plate by means of
multiple internal reflections, creating an evanescent field near the plate surface, which
exponentially decays in intensity into the supported membrane and the aqueous phase with a
decay length of approximately 300 nm. The membrane and the membrane-bound protein
molecules absorb a fraction of the energy of the evanescent field, while the molecules far from
the membrane do not contribute in the absorbance spectrum. Combination of the internal
reflection effect with the aligned sample and polarized light allows one to obtain information of
the molecular orientation in the sample due to the difference in absorbance efficiency between
the two polarizations of the incident light. The ratio of the absorbance intensities measured at
parallel and perpendicular polarizations of the incident light is called its ATR dichroic ratio,
RATR. In order to obtain information on the relative orientation of various secondary structure
elements of the proteins, dichroic spectra are generated by dividing the spectrum measured at
parallel polarization by the spectrum measured at perpendicular polarization. The values of the
dichroic ratios at a particular spectral region can be interpreted in terms of the spatial orientation
of the corresponding secondary structure element. Because the alpha helix is the predominant
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secondary structure in hIIA PLA2, and is well characterized in terms of polarized ATR-FTIR, we
will only consider the RATR for the alpha helical orientation. The physically meaningful limits of
alpha helical RATR are between 1.3 and 3.6, (three-phase approximation) or between 1.4 and 4.5
(two-phase approximation). See Appendix A: RATR. The maximum values (3.6 and 4.5) are
indicative of alpha helices that are perpendicular to the membrane surface, and the minimum
values (1.3 and 1.4) are indicative of alpha helices that are parallel to the membrane surface. For
isotropic samples with no defined orientation, the values of the dichroic ratios are Riso = 1.72 or
2.0 for the three- or two-phase approximations, respectively, but these dichroic ratios can also
correspond to a specific molecular orientation tilted away from the membrane normal by 54.7°.
Spectra of the three hIIA PLA2 proteins, bound to supported bilayers composed of 70:30
POPC:POPG (30% PG), were measured at parallel and perpendicular polarizations of the
incident light. The relative line-shapes of the amide I spectra are similar for hIIA PLA2 and
V3W, but are significantly different for the F5W mutant (Figure 31). The RATR in the alpha
helical region for hIIA PLA2 is 1.58-1.65 and 1.60-1.63 for V3W. Because PLA2 consists of
three different alpha helices, the dichroic ratio is the averaged ratios for all three, and therefore
cannot be interpreted in a straightforward manner. However, a generalization can be made using
the Riso values as a reference: because the alpha helical RATR values for the hIIA PLA2 and V3W
are less than Riso, it can be inferred that the helices are oriented more parallel to the planar
surface of a 30% anionic bilayer.
As expected, the dichroic spectrum (Figure 31 D) of the F5W mutant strongly deviates
from those of hIIA PLA2 and V3W. The F5W alpha helical RATR is ~1.3, the minimum value for
the three phase RATR approximation, indicating that the general orientation of the three helices of
the F5W mutant lie nearly parallel to the membrane surface. The fact that the value of RATR is
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beyond the lower limit set by the two-phase approximation for an alpha helix, reflects the
distortion of the helical structure in the F5W during membrane binding. Altogether, these data
clearly indicate that while hIIA PLA2 and V3W adopt similar and apparently productive
orientations at the membrane surface, the orientation of F5W is significantly different, which is
in line with the above findings of substantial deviations of the secondary and dynamic structures
of membrane-bound F5W as compared to hIIA PLA2 and V3W.

Figure 31 Polarized spectra
Amide I spectra at parallel (solid line) and perpendicular (dotted line) polarizations of the
incident light of membrane-bound A) hIIA PLA2, B) V3W and C) F5W; and D) the dichroic
spectrum of each, as indicated
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PLA2 Orientation to the membrane surface: Algorithm We have determined the precise
orientation of the hIB PLA2 enzyme relative to the membrane surface, using a technique that
exploits the unique data obtained from polarized FTIR spectroscopy, and depth dependent Trp
quenching to use as fitting parameters for a novel analytical geometry algorithm detailed in
Appendix B

82; 83

. Curve-fitted ATR-FTIR amide I spectra at parallel and perpendicular

polarizations were used to determine the ATR dichroic ratio of the α-helical component of the
membrane-bound N10-hIB peptide (RαATR) The α-helical ATR dichroic ratio of the peptide was
1.51 ± 0.17. Values of RαATR can be used to determine the α-helical order parameters, S,
(Appendix A: Order parameter). The value of RαATR = 1.51 ± 0.17 corresponds to an average
order parameter for the membrane-bound N10-hIB peptide of –0.205, varying in the range
between –0.033 and –0.405. The order parameter can be interpreted in terms of an average angle
(θ ) between the helical axis and the membrane normal (perpendicular to the membrane surface,
see Appendix A: Figure 40), therefore, we find that the helical axis of the membrane-bound N10hIB peptide is tilted from the membrane normal by ~64°, and the experimental error in the value
of θ is approximately ±10°.
For the full-length hIB PLA2, RαATR was 1.36 ± 0.12. In contrast to peptides that comprise a
single α-helix, like the N-terminal peptide, the helical dichroic ratio of a protein that has more
than one helix cannot be readily interpreted in terms of helical orientation because at a given
orientation of the protein with respect to the membrane, different helices may be oriented
differently. However, in some specific cases, e.g., for a protein containing two helices,
measurements of the helical dichroic ratios of one helix and of the entire molecule, bound to the
membrane, can provide the orientations of both helices, which then can be used to position the
protein molecule relative to the membrane

116; 125

. These procedures require information on the
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number of helices and their relative arrangement within the protein molecule. Since the structure
of hIB PLA2 is not available, we have used the coordinates of the crystal structure of porcine IB
PLA2 (PDB code: 1P2P), which shares 88% sequence identity with its human counterpart.
Analysis of the 1P2P structure identified three major (i.e., more than one turn) α-helices,
residues 1-9 (H1), 39-55 (H2), and 91-105 (H3). We have used the Cα atom coordinates to
determine the interhelical angles (Figure 32), using a newly developed algorithm 82.

Figure 32 Interhelical angles
The angle between the axis of the N-terminal helix (H1) and helix 2 (H2) θ, is designated η12. The angle
between the N-terminal helix and helix 3 (H3) is η13, and the angle between H2 and H3 is η23.

Our calculations yielded the following angles: 37.2° between helices 1 and 2 (η12), 37.7°
between helices 1 and 3 η13), and 4.2° between helices 2 and 3 (η23). Here N-C or C-N directions
of helices are not taken into consideration because helices at tilt angles θ or θ ± 180° yield the
same infrared dichroism. This indicates that H2 and H3 are virtually parallel to each other.
Therefore, we can ascribe a single orientational order parameter to H2 and H3, which we define
S2. This specific situation allows us to use the α-helical order parameter of the hIB PLA2 Nterminal α-helix (S1 = -0.205) and the total α-helical dichroic ratio of the full-length hIB PLA2
protein ( RαATR
= 1.36 ± 0.12) to determine the order parameter of H2-H3 (S2) in the membraneT
bound hIB PLA2 molecule

125; 126

. We find then, that the order parameter of H2-H3 of the
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Figure 33 hIB PLA2 quinary structure
A model for membrane binding of human pancreatic PLA2 that emerges from determination of the orientation of the α-helices of the protein
relative to the membrane normal. The protein backbone structure is based on the crystal structure of porcine pancreatic PLA2 (PDB code: 1P2P),
which shares identical function and 88% sequence identity with the human enzyme. The protein is shown in a ribbon format, with the N-terminal
helix colored magenta and the other two helices colored yellow. The key residues of the interfacial binding surface, as well as the catalytic residue
His48, are shown in a ball and stick format. The membrane surface is in the XY plane and is shown by a mesh of sky-blue spheres. Z is the
membrane normal. Each phospholipid polar headgroup can be imagined to consist of two spheres, which may represent, e.g., the phosphate and
choline moieties of phosphatidylcholine. The angles that the Z axis makes with the N-terminal α-helix and with the other two helices are shown.
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full length hIB PLA2 is: S2 = -0.43 ± 0.2, which indicates that the tilt angle of H2-H3 from the
membrane normal is θ ≈ 77° and varies within the range between 66 and 90°. This means that
these helices are strongly tilted away from the membrane normal and are nearly parallel to the
membrane surface. The knowledge of the orientations of the helices of hIB PLA2 with respect to
the membrane normal allowed us to position the protein at the membrane surface with a unique
angular orientation, as shown in Figure 33.
Next, we used similar procedures to assess the orientation of the membrane-bound
hIBΔN10 fragment. Here the simple one-helix approach is applicable because the two helices in
the protein are parallel to each other. The α-helical ATR dichroic ratio of the hIBΔN10 fragment
was 1.68 ± 0.13, which corresponds to an average order parameter for H2-H3 in the membranebound hIBΔN10 fragment of Sα,fr. = -0.033, with variation between -0.162 and +0.084. The
variations of the estimated order parameters for all three molecules, i.e. the full-length hIB PLA2,
the N10-hIB peptide and the hIBΔN10 fragment, are likely to result from different sources, such
as the fluid nature of POPC/POPG membranes, surface roughness of the internal reflection plate,
and a certain distribution around an average molecular orientation
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. In other words, the real

fluctuations of the order parameters characterizing the orientations of the molecules relative to
the membrane must be smaller than the limits of experimental uncertainties presented above.
The fact that the order parameter of the membrane-bound hIBΔN10 fragment is close to
zero (-0.033) is very likely to indicate a random, isotropic orientation of the molecule at the
membrane surface. The membrane binding isotherms of the hIBΔN10 fragment, which, unlike
those of the full-length hIB PLA2 and the N10-hIB peptide, are nearly linear and do not show a
tendency to saturate (Figure 14), are also indicative of nonspecific binding. Taken together, the
RET and ATR-FTIR data indicate that while the full-length hIB PLA2 binds to the membrane
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surface at a specific orientation, the binding of the hIBΔN10 fragment is weaker and nonspecific.
This conclusion is further reinforced by the fact that the N10-hIB peptide itself binds to
membranes with high affinity and at a defined orientation. Altogether, these data suggest that the
role of the N-terminal α-helix of hIB PLA2 is not only to increase the binding affinity of the
enzyme for the membranes, but primarily to properly orient the hIB PLA2 molecule and facilitate
its productive mode interaction with the membrane.
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PLA2 Orientation to the membrane surface: segmental labeling We have also
determined the orientation of a chimeric protein, in which the first 10 N-terminal residues of hIB
PLA2 have been substituted for the first 10 N-terminal residues of hIIA PLA2. The
experimentally derived membrane orientation of both hIB PLA2 and hIIA/IB chimeric PLA2
creates an unprecedented opportunity to evaluate the contribution of the N-terminal helices in
positioning the enzyme relative to its aggregated substrate, providing a unique insight into the
subtleties of structure function relationships. As the structure of the human IB PLA2 has yet to be
determined, the structure of the porcine IB PLA2, which has a 88% sequence identity to the hIB
PLA2, was used as a template to obtain the hypothetical structure of the IIA/IB PLA2 chimera
from the internet based server Swiss-Model

128

. The model, as expected, had the same global

structure as the IB PLA2 enzyme but the interhelical angles, (Figure 32) for the chimera were
slightly different from the IB PLA2. The angles, η12, η13, and η23 were 35.5°, 36.6° and 6.2° for
the chimera, and 37.2°, 37.7° and 4.2° for the hIB PLA2, which is not surprising, considering the
flexibility of the hIIA PLA2 N-terminal helix to shift in or out by 1Å 117.
The other parameters used were the RαATR values obtained by polarized FTIR of the
hIIA/IB PLA2 chimera and a peptide comprised of the first 10 N-terminal residues of hIIA PLA2
(N10-hIIA peptide) under the same experimental conditions as the hIB PLA2, and the depth of
the hIB Trp3 residue, translated to fit the smaller Val3 of the IIA N-terminal helix (10 Å from the
membrane center). The RαATR values for H1 and H2-H3 were 1.45 and 1.35, obtained by
differentially labeling the hIBΔΝ10 fragment before ligating it to the unlabeled N10-hIIA
peptide, and yielded the order parameters of Sα1 = -0.268 and Sα2,3 = -0.392 which in turn
translate to angles of ~67° and 74° from the membrane normal. The complete description of the
methods employed and resultant orientation including the positioning of key binding residues for
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Figure 34 hIIA/IB PLA2 chimera quinary structures
The hIIA/IB PLA2 chimera is presented in a ribbon format, with the α-helices H1, H2, and H3 colored yellow, purple, and light blue, respectively.
The side chains of amino acids directly involved in physical interactions with the membrane are shown, hydrophobic residues in green and the
cationic residues in blue. The catalytic His48 is shown (rose). The three layers of non-protein atoms are introduced to schematically show
membrane sections corresponding to the acyl chain terminal methyl carbons (gray), the sn-1 carbonyl oxygens (red), and the phosphorus atoms
(orange) of membrane glycerophospholipids. The z-coordinates of these layers are 0, 14.5 Å and 20 Å, respectively. In panel B, the protein has
been rotated by 10 degrees about an axis parallel to the X-axis, which results in immersion of Leu64 and Leu65 into the hydrophobic part of the
membrane.
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both enzymes can be found in Qin et al., 2004, 2005,81; 83 and also in Tatulian, 200582.
The comparison of the two enzymes demonstrate the precise three dimensional
orientation of chimeric IIA/IB PLA2 relative to the surface of the membrane (Figure 34) is
different than hIB PLA2 (Figure 33), and that the orientational difference is mediated by the Nterminal alpha helix. The near complete loss of activity for hIBΔN10 fragment, coupled with the
60% reduction in activity for the hIIA/IB PLA2 chimera, demonstrates the functional
significance of orientation for these enzymes to facilitate its productive mode interaction with the
membrane.
Ultimately, the precise orientation of hIB and hIIA/IB chimeric PLA2 provides evidence
that the N-terminal helix of group I/II PLA2s acts as a regulatory domain to mediate and support
interfacial activation of these enzymes by enhancing the membrane binding strength, conferring
conformational integrity and plasticity to the enzyme, and ultimately facilitating a productivemode orientation of shPLA2 at the membrane surface.
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CHAPTER FOUR: ORIENTATION AND ACTIVATION
Interfacial activation is the term initially used to describe the large rate differences
observed between the minimal hydrolysis of soluble monomeric substrate (below the substrate’s
critical micellar concentration, CMC), and the rapid hydrolysis of aggregated substrate such as
micelles or vesicles. The term also includes an apparent induced change in catalytic efficiency of
the enzyme at some point after binding, characterized by a lag phase of relatively low catalytic
activity followed by a burst of enhanced activity, an ‘activation’ of the enzyme mediated by
interfacial binding. In order to elucidate the activating mechanism, many high resolution
structures of these enzymes have been generated, both free in solution and bound to substrate
mimics or inhibitors, with and without micelles

66; 68; 80; 104; 117

). Additionally, the kinetics of

binding to aggregates has been effectively separated from the kinetics of the catalytic event by
careful design of the experimental conditions, allowing independent evaluation of these two
steps 60; 129; 130; 131.
Through these foundational experiments, interfacial activation has been solidly correlated
to the physical state of the substrate: aggregate curvature and packing order (a determinant of
membrane fluidity), and other morphological determinants, including surface charge and
topology of the phospholipid head-groups, as well as lateral phase separation, and membrane
disruption 89; 90; 102; 132; 133. The lag phase is most pronounced on zwitterionic substrates, and has
been observed to decrease with increasing concentrations of anionic components within the
aggregate 55; 57; 118; 134. However, the anionic activators, such as the phospholipids PG, PA, or PS,
or the anionic amphiphile, cholesterol sulphate, vary in their ability to activate different
phospholipase A2 isoforms. For example, PA is an effective activator of group IB PLA2 enzymes
but is ineffective for hIIA PLA2, and between the anionic equivalent phospholipids PG and PS,
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only PG is an effective activator of hIIA PLA2. The burst of activity was correlated to the time
dependent buildup of anionic products within the aggregate, implying that the activating
mechanism was simply a consequence of an increase in the number of enzymes bound. However,
Burack et al., 1995 92 demonstrated that most of the enzyme is bound to the substrate well before
the burst of activity, implying the presence of a relatively inactive state.
Conformational changes within the enzyme were evaluated through atomic resolution
methods. Crystal structures of the enzyme alone or bound to an inhibitor or substrate mimic,
revealed no structural differences between the two conditions

135

. However these structures do

not represent the conformation of the enzyme bound to substrate aggregates, only single
substrates within the substrate binding site. A solution structure of the pIB PLA2 isoform, bound
to a substrate mimic in the presence of micelles, revealed an ordering of the first three residues of
the N-terminal helix upon binding, which directly affected the hydrogen bonding network of the
catalytic site, implying possible allosteric effects mediating interfacial activation 80; 106. However,
the solution structures of group IIA PLA2 enzymes, which demonstrate the greatest change in
catalytic rates, do not show any differences in the helical quality of N-terminal alpha helix
between the bound and unbound states, but did demonstrate a 1Å shift of the whole helix
between bound and unbound states 104.
Qualitative methods employed by our lab also revealed possible allosteric mediators, in
that upon binding to supported bilayers, the secondary structures of a group IIA PLA2 from the
eastern cottonmouth, Agkstrodon piscivorus piscivorus (AppD49), were more dynamic than in
solution

56; 119

. In this work, the HDX kinetics results from hIIA PLA2 and V3W are in

agreement with the AppD49 results, revealing a more dynamic structure upon membrane binding
than in solution. However, the inverse was seen for hIB PLA2, where the efficiency of HDX
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exchange was reduced upon membrane binding, implying a stabilization of its secondary
structure components. Interestingly, the results from the chimeric protein demonstrated a more
rigid structure for helices 2 and 3, from hIB PLA2, and a more flexible structure for the Nterminal helix, from hIIA PLA2, than the native hIB PLA2 enzyme.
Site directed mutation or labeling methods have been extensively employed, in order to
determine the specific residues involved in binding, and the contribution of those residues to
interfacial activation

57; 66; 72; 76; 136; 137

. These studies reveal not only group specific but species

specific residues that are involved in substrate recognition, binding, and catalytic activity. These
residues are most often lysines or arginines, hence the effects of the concentration of anions in
the membrane. However, binding and activation can not be attributed to electrostatics alone,
hydrophobic interactions, mediated especially by tryptophan or phenylalanine also play a
significant role in the toxicity of the snake venom isoforms 67; 138. Ultimately, these experiments
produced a consensus of key substrate binding residues: hydrophobic residues surrounding the
opening to the substrate binding site, key interfacial binding residues on the external face of the
N-terminal helix, most notably in positions 2, 3, 7 and 10, with other species specific residues in
various positions across the surface and along the edges of the IBS.
From the above results it is evident that interfacial activation is mediated by both enzyme
and substrate associated factors. Other experiments reveal a third contributor: solvent
interactions. It is understood that the single substrate must move from the confines of the
aggregate into the substrate binding pocket of the enzyme. Though not directly addressed in most
of the literature, it is implied that this transfer is mediated by diffusion; is considered either part
of the catalytic step in the kinetic scheme or precedes the activation step; and is precluded by the
enzyme binding to the aggregated substrate. In order for the single substrate to leave the
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energetically favorable environment of the aggregate, it must not encounter any barriers to that
migration. It is not surprising then, that the dehydration of the substrate interface in direct contact
with the enzyme, was observed under kinetic conditions of constant, enhanced activity i.e. on
100% anionic substrate

129

. This observation was inferred from Trp3 fluorescence quenching

experiments on pIB PLA2, similar to the experimental methods employed here which
demonstrated an incomplete protection from the aqueous quencher, acrylamide, for V3W, F5W,
hIB PLA2, or N10-hIB peptide on 50% anionic lipid, or for hIB PLA2 and N10-hIB peptide on
100% anionic lipids. Berg et al., 2004

139

suggested that the allosteric activation of PLA2 was a

result of the dehydration of the interface upon binding of the enzyme to the aggregated substrate.
In fact, ATR-FTIR methods revealed a conformational change of the supported bilayers induced
by binding of AppD49, increasing the order parameter of fluid membranes and decreasing the
order parameter of gel state membranes 56. Interestingly, AppD49, upon covalent modification of
the catalytic His48 (an internal residue), demonstrated no such effects upon the membrane; nor
did it undergo the dynamic structural changes noted with the unmodified enzyme 56. These data
suggest a dehydration of the membrane by PLA2, with a concomitant formation of hydrogen
bonds to the membrane. Although the work of Gadd and Biltonen, 2000, 140 neatly correlated an
increase in activity and level of dehydration to the concentration of anionic phospholipids within
the membrane, the precise mechanism has yet to be defined.
Because the conservative substitution of a single residue, Val3 with Trp, resulted in a very
large enhancement in the catalytic rate of the human IIA PLA2 isoform, we focused our
continued search for the mechanism of interfacial activation on this mutation. We also generated
a novel conservative substitution, Phe5 for Trp, in close proximity to the third position, only on
the internal face of the key N-terminal helix. The only difference noted between hIIA PLA2 and
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V3W, was the level of activity. The rate difference was seen in a system of mixed micelles, on a
substrate near the gel to fluid transition state, and in the initial phase of hydrolysis on 15%
anionic substrate. There were no notable structural differences either in solution, or bound to
30% anionic supported bilayers, nor were there any differences in the dynamic structures in the
same conditions. There weren’t any major differences noted on the strength of binding,
accessibility to solvent and membrane associated quenchers, or the depth of membrane insertion
of the Trp3 residue (compared to the native Trp3 from hIB PLA2).
The clues to the mechanism of interfacial activation were found in the surprising
retention of activity of F5W on 15% anionic bilayers, and the reduction in activity of the
chimeric enzyme, as well as the almost total loss of activity for the truncated hIBΔN10 fragment.
If binding to the aggregated substrate and proximity of the active site to the monomeric substrate
were the only two criteria for activity, the hIBΔN10 fragment should have demonstrated a
greater level of activity than what was seen. If the presence of the N-terminal helix was crucial to
activity, then the chimeric enzyme seemingly should have demonstrated a higher level of
activity. The differences revealed in this work are in the results from the ATR-FTIR experiments
of F5W upon binding to supported bilayers. Under conditions where the enzyme is presumed to
be active, (F5W demonstrated activity on 15% anionic bilayers), there was a noticeable
disruption in the dynamics and quality of the secondary structure, which was also associated with
a change in orientation of the enzyme to the substrate,
While many groups have alluded to the orientation of the enzyme to its substrate as a
possible factor in the mechanism of interfacial activation, only a few have postulated an
orientation of the enzyme to its substrate

74; 94

. This was done by interpreting results from

indirect methods, i.e. mutation of IBS residues and spin labeling experiments. We have oriented
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the enzyme by applying the direct measurements of the enzyme’s angular orientation, while
bound to supported membranes, to a novel algorithm that exploits the intrinsic geometric nature
of helices, translation dipole moments and electromagnetic vectors. The output of the algorithm
is the translation of the established atomic coordinates of the enzyme to the coordinate system of
the supported bilayer, specifically orienting the enzyme on its substrate.
It is evident that each homologous phospholipase A2 isoform has unique, group specific
and also species specific residues that determine the isoform’s functional specificity. One prime
example is the distribution of positive charges over the entire surface of the human group IIA
PLA2 facilitating the enzyme’s specific targeting of bacterial membranes, while effectively
ignoring the PC rich plasma membranes of self cells. This residue mediated specificity can be
viewed as an orchestrated combination of noncovalent bonding: hydrogen, ionic, hydrophobic
and van der Waals interactions, which determine not only selectivity and affinity of the enzyme
for the substrate aggregates, but also the orientation of the enzyme to the surface.
The conclusion most evident in the reconciliation of this work with the existing body of
knowledge is that, the phenomenon of interfacial activation is mediated by simply optimizing the
orientation of the enzyme to the interface. The accumulation of anionic product promotes a
stronger interaction between the enzyme and aggregated substrate. This induces a dynamic
conformational shift in the enzyme, accompanied by a topographical remodeling of the
aggregate, resulting in a productive orientation of the enzyme to the interface. The tight binding
induces a dehydration of the interface, allowing the monomeric substrate to enter the enzyme. It
may seem that this is simply a statement of the obvious. It is. The mechanism for interfacial
activation is revealed by a careful scrutiny of the obvious.
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In order to definitively describe the mechanism of interfacial activation, the kinetic
scheme proposed by Berg et al., 2001

60

(Figure 6) must be rearranged, redefined and expanded

to include the two binding states of the enzyme, the transfer of monomeric substrate to the
enzyme, and the movement of the enzyme along the interface (Figure 35).

Figure 35 Expanded interfacial kinetic scheme
Expanded schematic diagram of the interaction between an interfacial enzyme and its aggregated
substrate. E* denotes the membrane bound enzyme, S the aggregated substrate, s the single phospholipid
substrate and P the products which are shown in red. The plus sign, (+) indicates separate entities, the dot
indicates a loose association, the absence of either is the complex of either bound enzyme and substrate,
or bound enzyme and product. The rate constants are: dissociation (KD); interfacial activation (K#), which
has been moved to an earlier point describing the change in enzyme-aggregate interaction from a loose
association to a close dehydrated state; recognition of the substrate by the activated enzyme (K1),
movement of the momomeric substrate into the enzyme (Ks*); the rate of catalysis (Kcat), which includes
the dissociation of product back into the aggregate; and the movement of the enzyme across the interface
(K2).

The two bound states, inactive and active, have been clearly demonstrated by
experimental and theoretical approaches. This certainly defines the first step in activation, hence
the rearrangement of the activating step, and activating rate constant, K#.
K1 describes the infinitely brief interval between the tightly bound enzyme without
enzyme and the initial recognition of the monomeric substrate: E*+s → E*·s. The inclusion of
this step is necessary, in order to isolate the transfer of the monomeric substrate from the
aggregate into the enzyme, decoupling the rate constant constrained by the state of hydration
between the enzyme and aggregated substrate, from the catalytic event. Ks* is redefined as the
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rate constant for the transfer of the substrate monomer as it moves from its energetically
favorable environment in the aggregate across the interface into the hydrophobic environment of
the enzyme. Factors which determine this rate are: i) the presence of the divalent cation, calcium
within the binding cleft, evidenced by the dependence of calcium on substrate binding 71; ii) the
size of the opening to the cleft, evidenced by the differences seen between IB, IIA and group V
104; 141

; iii) key residues that interact with the headgroup of the substrate, Lys56 for group IB and

Glu56 for group IIA

104; 142

; and iv) the distance which must be traversed, which determines the

amount of water the substrate encounters in between the two hydrophobic environments,
evidenced by the two bound states and the correlation of increased activity with increased
dehydration resulting from the increase of anionic charge in the membrane reported by Gadd and
Biltonen, 2000 140.
In soluble enzymes, substrate binding is mediated by diffusion of the substrate into the
binding pocket of the enzyme. The steady state rate, or vmax is attained, when the concentration of
substrate is much greater than the concentration of enzyme, effectively eliminating the rate
limiting constraint of diffusion. With interfacial enzymes, in theory, the concentration of
monomeric substrate is at a maximum, as the nature of the aggregate provides maximum packing
of the substrate, which in turn is in physical contact with the enzyme. The lateral movement of
the enzyme across the interface is implicit in the catalytic turnover step, along with the product
dissociation from the enzyme, defined by Jain et al., 1986 143 as the “scooting mode”. Therefore,
in order for the enzyme to reach vmax, the accessibility of uncleaved substrate by movement of
the enzyme across the aggregate must be unimpeded. Therefore, I include the contribution of
lateral movement of the enzyme as a separate event with a unique rate constant, k2. The
maximum facilitated transfer of substrate into the catalytic cleft, combined with the rapid

93

replenishment of uncleaved substrate seen in the ‘scooting mode’ is analogous to supersaturating
solution enzymes, and true vmax is revealed.
The final piece to the puzzle clearly defining the mechanism of interfacial activation is
found in an obscure work in the early development of molecular dynamics (MD), a simulation of
the interaction between separate molecular entities, such as PLA2 and its aggregated substrate 144.
The molecular dynamics study entailed simulating the binding of hIIA PLA2 onto dilaurylphosphatidylethanolamine (DLPE) in silico. The conformation, dynamics and energetics of the
enzyme both in solution and bound to DLPE in two different modes: loose and tight were
evaluated. The interactions between protein and lipid molecules were analyzed and the free
energies of solvation for the lipids at the interface, as well as dielectric susceptibilities at the
interface, were calculated. The results clearly show a dehydration of the headgroup region of the
membrane only in the tight configuration, and reveal a thin layer of water molecules between the
enzyme and substrate interface in the loose configuration. The elusive mechanism of interfacial
activation was revealed in the calculations of the free energies of solvation, a measure of the
energy barrier required to cross in order for a substrate monomer to transfer from the stable
environment of aggregated lipids into the enzyme. The required lowering of the energy barrier
was localized only to the lipids interacting with the hydrophobic residues surrounding the
opening to the active site, the hydrophobic collar, making them “ideally situated to induce an
accelerated diffusion of lipids into the enzyme”. This accelerated diffusion enables the
realization of the enzyme’s true vmax, and because it is inextricably tied to the state of
dehydration, has only been indirectly detected as interfacial activation.
The clear dependence of interfacial activation on the orientation of the enzyme to the
substrate can now be demonstrated. Beers et al., 2003

94

74

, individually mutated each of the

hydrophobic collar residues found in hIIA PLA2 to Trp, including Val3. The results from the
activity and binding assays were seemingly inconsistent, most notably with the V3W mutation.
However a Val3, Val31 double mutant, (V3,31W), consistently demonstrated the highest rate of
activity on either 100% DOPG vesicles in a high salt buffer, or on 100% DOPC vesicles with 0.1
M NaCl in the buffer. They noted that the double mutant displayed a similar ability to effectively
catalyze either zwitterionic or anionic substrate demonstrated by group V PLA2, but could not
offer a definitive explanation for the seeming lack of specificity (group V has a native Trp31, but
not Trp3, it has a Leu3 instead). It is now necessary to look at the tertiary structure of hIIA PLA2
to understand the consequence of the V3,31W double mutant as it pertains to orientation and
interfacial activation. Several atomic resolution structures have been determined, 1N29 117 is the
solution structure of the N1A mutant hIIA PLA2 used in this work, but we will also use 1POD
104

, used by Canaan et al., 2002 94, to orient the molecule to micelles spin labeling results, and

1BBC

145

used by beers to model the 15 degree difference in orientation on 20% or 100%

DOPG74. Both 1POD and 1BBC are wild type hIIA PLA2 structures determined by X-ray
crystallography. In all three structures, it is clearly evident that the Val3 and Val31 residues reside
on opposite sides of a ‘hinge’ created by Phe24 and Phe70. A similar hinge was described by
Canaan et al., 2002,94 across Lys10 and Phe63 (Phe70 by the core numbering system) but was
based on 1POD, with the stated assumption that the conformation of the enzyme does not change
significantly upon interfacial binding.
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Figure 36 Space filled models of hIIA PLA2
Comparison of three atomic resolution structures of hIIA PLA2, demonstrating motional flexibility of
surface residues. hydrophobic collar residues are in yellow, cationic residues blue and anionic residues
red. Structures rendered with CN3D, NCBI’s structure visualization program 146.

There is no doubt that the tertiary structure is relatively rigid, as it is held together by
disulfide bonding, but the sidechains, which are exposed to solvent, are not constrained, so
should be quite flexible. A side by side examination of space filling models of 1N29, 1BBC and
1POD, reveals very different conformations for every external residue (Figure 36).
In addition, preliminary results from NMR spectra of 15N13C labeled hIIA PLA2 both free
in solution and membrane bound, determined by our collaborators, Jeffery Urbauer at the
University of Georgia, reveal significant structural changes that occur in the presence of d38dodecylphosphocholine (DPC) micelles, as is indicated by chemical shift changes of many of the
observed peaks (Figure 37, Table 12).
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Figure 37 NMR 2D spectra of hIIA PLA2
Overlay of 2D 1H, 15N-HSQC NMR spectra of calcium loaded human group IIA phospholipase A2. Final
protein concentration was ~1 mM [U-13C, 15N] hIIA PLA2, in the presence (red) and absence (yellow) of
100 mM d38-dodecylphosphocholine (DPC). The spectrum were acquired at 600 MHz, 25 ºC, in a buffer
containing 50 mM NaCl, 5 mM EGTA, 25 mM CaCl2, 5 mM d4-imidazole and 0.02 % sodium azide in
93 % H2O, 7 % D2O, pH 6.5 (pH reading not corrected for D2O isotope effect). The main chain resonance
assignments have been completed, following a standard triple resonance approach.
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Table 12 Assigned peaks from NMR spectra overlay
Out of a total of 116 assigned peaks, 21 did not move, 37 shifted and 58 moved completely, giving 18, 32
and 50%, respectively. The residues are clustered according to sequence.

According to Dr Urbauer, these results demonstrate a strong, dynamic interaction of the
enzyme with the micelles.
An inspection of the Cartesian coordinates for the hydrophobic collar residues reveal a
planar topology for Phe24 and Phe70 residues, which sits above another plane, in which lie the
smaller Val3 and Val31 residues (Figure 38). The hinge relationship of these four residues can be
described as a four legged table with two shorter legs on diagonal corners. Replacing both
valines, the shorter legs, with tryptophans (V3, 31W) would effectively eliminate the ability of
the table to wobble back and forth (the hinge effect) about the line connecting the two longer
legs. Thus the balancing of the bulkier Phe residues with residues that demonstrate an affinity to
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sit at a specific depth in the interface would facilitate and induce the localized dehydration which
mediates interfacial activation.

Figure 38 Two planes
The hydrophobic collar residues Phe24 (light blue) and Phe70 (dark blue), lie in one plane perpendicular to
the page; while Val3 (light purple) and Val31 (dark purple) lie in a lower plane nearly parallel to the first.
Each plane is defined by a third residue, Leu19 and Ala18, respectively, not shown for clarity. The view in
the right panel is approximately 90°, rotated counter-clockwise, from the left panel.

Applying the same logic to the inconsistent rates exhibited by the single V3W mutation
toward zwitterionic membranes, presented in the same work as V3,31W
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, reinforces the

dependence of interfacial activation on orientation. The role Trp3 in the ability of IB PLA2 to
hydrolyze zwitterionic membranes was clearly demonstrated by the reduction in catalytic activity
by the Trp3 to Phe mutation of hIB PLA2 147. As Trp has been shown to specifically interact with
hydrophobic interfaces, it can be assumed that the substitution of Val with Trp would induce a
tighter interaction with the membrane, hence the observed catalysis of zwitterionic substrate by
both the V3,31W and V3W mutant of hIIA PLA2. However as noted by Diraviyam and Murray,
2006
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, the apparent ‘blindness’ of the wild type hIIA PLA2 can be solidly attributed to a

repulsion of the cationic residues dispersed over the entire enzyme by the cationic charges in the
zwitterionic substrate. These two diametrically opposite forces along the IBS of V3W, orient the
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enzyme in such a way as to exploit the inherent dynamic nature of the N-terminal helix, as well
as the flexibility of the same helix and at the same time optimize the hydrophobic interactions at
the opening to the substrate binding pocket. The result of this unique orientation of V3W is seen
in the exceedingly large rate enhancement, and subsequent ‘deactivation’ in the activity profile
on 15% PG presented in this work. The large rate reduction seen here can be attributed to the
accumulation of the anionic products, which effectively reverses the electrostatic repulsion
effects, and consequently reorients V3W in a manner similar to the wild type, and therefore,
demonstrates a similar catalytic rate as the wild type. (This proposed similarity in orientation
between V3W and hIIA PLA2 on substrate aggregates with greater than 30% anionic substrate, is
seen in the absence of any major differences detected by the variety of biophysical methods used
in this work.) The dramatic change in the catalytic efficiency of hIIA PLA2 by a single key
interfacial binding residue change, can thus be attributed to the orientation of the enzyme to the
aggregated substrate.
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CHAPTER FIVE: CONCLUSIONS
We produced large quantities of labeled and unlabeled pure protein, suitable for structural
determination, through calculated modifications of established protocols. We evaluated the
biochemical and structural consequences of two conservative, single residue substitutions,
located at key positions within the primary sequence of hIIA PLA2. We also evaluated the
hIBΔN10 fragment, missing the N-terminal alpha helix, as well as the substitution of that helix
with the N-terminal alpha helix from hIIA PLA2. We compared the engineered proteins against
both the hIIA and hIB PLA2 native enzymes and their N-terminal peptides, N10-hIB and N10hIIA. We implemented a novel algorithm, in order to position the segmentally labeled hIB and
hIIA/IB chimeric PLA2 onto the aggregated substrate in an experimentally determined
orientation. These results reveal subtle structure function relationships that contribute to the
regulation of the specificity, allosteric modulation and catalytic rate of these very significant
enzymes. This work clearly underscores the functional importance of the residues Trp3 and Phe5,
in that Trp3 in the V3W mutant facilitates the productive mode binding of hIIA PLA2 to
membranes where Trp5 in the F5W mutant tends to interact with the membrane and hence causes
conformational perturbation in the protein. In addition, this work provides evidence that
structurally similar group hIB and hIIA PLA2s, significantly penetrate into membranes and that
membrane insertion is controlled by membrane fluidity and facilitates activation of hIIA and hIB
PLA2s. In addition, we show that the N-terminal helix of group I/II PLA2s acts as a regulatory
domain which mediates and supports interfacial activation of these enzymes by enhancing the
membrane binding strength, conferring conformational integrity and plasticity to the enzyme and
ultimately facilitating a productive-mode orientation of shPLA2 at the membrane interface.
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The major contribution of this work, is the reconciliation of the existing body of
knowledge with our current work, yielding a comprehensive proposal for the mechanism of
interfacial activation: i) the orientation of the enzyme to the substrate, mediated by specific IBS
residues such as Trp3, determines the level of dehydration of the hydrophobic collar residues
surrounding the opening to the catalytic cleft, ii) the level of dehydration modifies the energies of
solvation, the energy barrier which must be crossed as the monomeric substrate is transferred
from the aggregate to the interior of the enzyme. The lag phase on zwitterionic substrates is a
result of this rate limiting state, iii) total dehydration of the interface, the result of a tight
interaction induced by specific IBS residues such as cationic residues on an anionic surface,
reduces the energy barrier to such an extent that the lowest energy state for the monomeric
substrate is no longer in the aggregate but within the enzyme. The burst of activity induced by
anionic product is a result of the interaction of this rate limiting condition. In short, the specific
orientation, including the depth of membrane insertion, of the enzyme toward its aggregated
substrate mediates the optimum activity of the enzyme, and by extension, is the mechanism for
interfacial activation.
The future direction of this work will entail reinforcing the validity of our conclusion.
The experimental design will incorporate ATR-FTIR methods in order to determine the relative
orientation of the enzyme to its substrate, via RATR of the hIIA PLA2, V3W and F5W enzymes on
supported bilayers composed of varying concentrations of negative lipids. The base lipids will be
POPC and DPPC to characterize the orientation on a liquid order or gel phase substrate.
Additionally, segmental labeling of hIIA PLA2 and V3W will yield the RαATR values, enabling
the precise orientation of the N-terminal helices relative to H2 and H3 on different compositions
of zwitterionic and anionic substrates such as DPPC, DPPG, POPC and POPG. The activity of
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the three enzymes will be correlated to their orientation through BisPy-PC fluorescence based
activity assays. The data will be compared to molecular dynamics simulations of the enzymes on
respective lipid substrates, generated using the updated MD software package (which models
atomic interactions, enabling a visualization of the movement of residues within the aqueous or
nonpolar matrix).
A new hypothesis arising from these conclusions will also be tested using the above
interdisciplinary experimental design: The translocation of the PLA2 enzyme, across the surface
of the aggregated substrate, is facilitated by the electrostatic repulsion of the single anionic
residue on the IBS of the enzyme with the newly formed anionic product in the membrane.

103

APPENDIX A: EQUATIONS

104

Equations 1 Determination of extinction coefficients

Unique extinction coefficients for hIIA PLA2, V3W, F5W and hIB PLA2 were
determined using the Beer-Lambert law:

Aλ = εcl

(Eq. 1)

Where Aλ is the measured absorbance at a specific wavelength (λ), ε the extinction coefficient, c
is the molar concentration, and l the pathlength through the cuvette, 0.4 cm in these experiments.
The molar concentration was determined using the molecular weights of the proteins based on
the amino acid sequence.

Equations 2 Specific Activity

Phospholipase A2 activity was recorded as the change in absorbance at 414nm (A414) over
a one minute interval and applied to Eq. 1 using the extinction coefficient of 5-thio-nitrobenzoic
acid (ε414 = 13,600 M–1 cm–1) and pathlength of 0.4cm. As the reaction progress is 1:1 (cleaved
product:5-thio-nitrobenzoic acid), the concentration of 5-thio-nitrobenzoic acid equals the
concentration of product. Dividing the concentration of product by the total amount of enzyme
within the reaction gave the specific activity in moles of product released in one minute per mg
of enzyme.
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Equations 3 BisPy-PC

Phospholipase activity against bis-pyrene labeled LUVs. The hydrolysis of BisPy-PC by
PLA2 separates the two pyrene functional groups on the terminus of the sn-1 and sn-2 acyl chains
of the phospholipid, resulting in a decrease in the excimer signal at 470 nm and an increase in the
monomer signal at 380 nm. There is not a linear relationship between the eximer and monomeric
signal therefore, the amount of BisPy-PC cleaved at any timepoint is expressed as the ratio of the
monomeric signal to the eximer signal at time t:
⎛F ⎞
Rt = ⎜⎜ 380 ⎟⎟
⎝ F470 ⎠ t

And the rate of activity was graphically represented as

Rt
−1
R0

over time, where R0 is the ratio of fluorescence intensities at 380 and 470 nm before the addition
of enzyme.
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Equations 4 FPE

Membrane binding on vesicles labeled with 2 mol% N-(fluorescein-5-thiocarbamoyl)1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (FPE). The fluorescence intensity of
FPE is sensitive to the ionization state of the carboxyl group of fluorescein; the emission
intensity increases with increasing deprotonation 81. The fluorescein moiety of FPE is located at
the interface of the negatively charged membrane, where the local environment is more acidic
than the bulk phase because of electrostatic attraction of protons to the membrane. This causes
partial protonation of the carboxyl group of fluorescein, resulting in a moderate level of
fluorescence intensity. Adsorption of cationic protein or peptide molecules to the membrane
reduces the negative surface charge of the membrane, which results in a protein (or peptide)
dose-dependent deprotonation of fluorescein and increase in the fluorescence intensity. The
protein is added to preformed lipid vesicles, resulting in binding of the protein to the external
surface of vesicles. If one considers that only a fraction δ of the total lipid is accessible to the
protein, and the binding of each protein molecule makes N lipid molecules inaccessible for other
proteins, then the dissociation constant of the binding process can be presented as:

KD =

([ P] − [ P] )(δ [ L] − N [ P] )
b

b

(Eq. 2)

N [ P ]b

where [P] and [L] are the total concentrations of the protein and the lipid, respectively, and [P]b
is the concentration of the membrane-bound protein. When the lipid fluorescence is monitored as
the lipid is being titrated with the protein, the relative change in the fluorescence signal is:
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[ L ]b
ΔF
=
ΔFmax δ [ L]

(Eq. 3)

where ΔF is the change in fluorescence intensity at a given protein concentration, ΔFmax is the
saturating level of ΔF at high protein concentration, and [L]b is the concentration of proteinbound lipid. We have used ΔF values at 518 nm. Using:

[P]b = [L]b/N = ΔFrelδ[L]/N

where ΔFrel ≡ ΔF/ΔFmax, we convert Equation 2 into a quadratic equation with respect to ΔFrel
and solve as:

N [ P]
δ [ L]

(Eq.4)

1 ⎛ N ( K D + [ P]) ⎞
+ 1⎟
⎜
⎠
2⎝
δ [ L]

(Eq.5)

ΔFrel = a − a 2 −

where a =

The plus sign in front of the square root is useless because it results in values of ΔFrel > 1. It is
seen from Equation 2 that at half-saturation of protein binding, when ΔFrel = 0.5:

K D = [ P]1/ 2 −

δ [ L]

(Eq. 6)

2N

where [P]1/2 is the protein concentration corresponding to ΔFrel = 0.5.
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Changes in FPE fluorescence intensity, ΔF, were measured at various protein
concentrations, [P], and ΔF were plotted against ΔF/[P]. These linear (Scatchard) plots were
used to evaluate ΔFmax and [P]1/2 from extrapolated intercept with the ΔF axis and from the
slope, respectively. Experimental binding isotherms were constructed by plotting ΔF/ΔFmax
against [P]. The theoretical isotherms were simulated through Equation 4 using KD and N as
fitting parameters. In spite of two fitting parameters, determination of both KD and N by this
method is reliable. In Equation 6, [P]1/2 can be determined using the experimental data, as
described above, and δ is 0.52 for vesicles 100-nm in diameter, with membrane thickness of 4
nm 83. Replacement of KD in Equation 4 by the expression in equation 6 yields an equation with
only one unknown, i.e. N. Hence, fitting of the experimental curves can be done by varying N in
a physically reasonable range and, once a best fit is achieved, KD can be calculated through
Equation 6 using the heuristically determined best fit value of N.
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Equations 5 RET

Membrane binding on vesicles containing 2 mol% Py-PE. Fluorescence intensities
obtained in RET experiments were corrected for dilution and for the increase in the fluorescence
emission as measured in control experiments. This was followed by calculation of the changes in
emission intensities at 330 nm for N10 peptide or full-length PLA2 and at 304 nm for ∆N10
fragment at each lipid concentration relative to the zero lipid level, ΔF. The first step of the data
analysis was evaluation of the saturating value of ΔF at high lipid concentrations, i.e. ΔFmax, and
the lipid concentration corresponding to half-saturation of binding, [L]1/2, at which ΔF = ½ΔFmax.
In order to do this, binding data were presented using a simple, Langmuir-type formalism:

ΔF = ΔFmax

[ L]
[ L]1 / 2 + [ L]

(Eq. 7)

where [L] is the total lipid concentration. Equation 7 can be re-arranged to show that the plot of
ΔF as a function of ΔF/[L] (Scatchard plot) is a straight line with a slope of –[L]1/2 and a ΔF-axis
intercept of ΔFmax. The Scatchard plots were constructed, using ΔF values at each [L], and the
parameters ΔFmax and [L]1/2 were evaluated from the plots. Then, the values of ΔFmax were used
to construct the experimental binding isotherms, i.e., the dependence of ΔF/ΔFmax as a function
of [L]. In order to describe the protein-lipid interaction, a bimolecular binding model was used148;
149

. According to this model, each free protein molecule binds to an unoccupied binding site at

the membrane surface. The lipid vesicles and the protein are mixed in a way that only a fraction
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δ[L] of the total lipid (i.e., the external lipid leaflets of vesicles) is accessible for the binding of
the peripheral protein. The bimolecular binding process can be described as:

Pf + δL f ⇔ Lb

(Eq. 8)

where the subscripts f and b indicate the free and bound state of the protein (P) or the lipid (L).
The dissociation constant of this binding process is:

KD =

[ Pf ][δL f ]

(Eq. 9)

[ Lb ]

where the brackets mean concentration. Also, since the area of the interfacial binding
surface of PLA2 (~1700 Å2) 60 is much larger than the cross-sectional area of POPC or POPG (68
Å2) 150, N >>1 lipid molecules are likely to be involved in formation of a binding site, i.e., [Lb] =
N[Pb]. Additionally, the number of lipids that constitute a binding site (N) for group I/II PLA2s
was determined in several studies and varied between 28 and 48

66; 151; 152

. The parameter N

should not be interpreted as the number of lipids that physically interact with a PLA2 molecule.
Instead, this is the effective number of lipids that constitute a protein binding site and become
inaccessible to other proteins upon binding of a PLA2 molecule to the membrane surface.
Also, [Pf] = [P] – [Pb], and δ[Lf] = δ[L] - N[Pb]. A key assumption of the model is that the
change in the protein fluorescence intensity at each lipid concentration is proportional to the
fraction of lipid-bound protein, i.e., [Pb]/[P] = ΔF/ΔFmax ≡ ΔFrel. Introducing all these into
equation 9, we obtain:
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KD =

([P] − ΔFrel [P])(δ [L] − ΔFrel N [P ])
ΔFrel N [P ]

(Eq. 10)

Equation (10) can be converted into a quadratic equation with respect to ΔFrel and solved as:

ΔFrel = b − b 2 −

where b ≡

δ [L]

(Eq. 11)

N [P ]

δ [L ] K D ⎞
1⎛
+
⎟.
⎜⎜1 +
2⎝
N [P ] [P ] ⎟⎠

In equation (11), the plus sign in front of the root is not used because it yields physically
meaningless (i.e., > 1) values for ΔFrel. At half-saturation of protein binding to membranes, [L] =
[L]1/2, ΔFrel = 0.5, and [Pb] = ½ [P]. Insertion of these in equation (10) yields:

KD =

δ
N

[ L]1 / 2 −

[ P]
2

(Eq.12)

In equation (12), the total protein concentration, [P], is known, [L]1/2 can be determined from the
experimental binding isotherms, as described above, and the fraction of the protein-accessible
lipid, δ, i.e., the fraction of the lipid in the external leaflet of 100-nm (in diameter) POPC/POPG
vesicles with membrane thickness of 4 nm is ~0.52 153. Thus, the dissociation constant, KD , can
be determined based on an experimental binding isotherm provided the number of lipid
molecules involved in a binding site, N, is known. We have used physically reasonable values for
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N to calculate corresponding values for KD through equation (12), and have used them to
construct theoretical curves, using equation (11), until a best fit with the experimental binding
isotherm was reached.
This is an accurate and stringent approach to determine binding parameters because it
does not allow selection of any values of KD and N for fitting the experimental results. There is
only a unique pair of parameters KD and N, which are interrelated through equation (12) that can
provide a best fit with the experiment. Binding energies were deduced from dissociation
constants as ΔGb = -RT(ln[W] – lnKD), where [W] is the molar concentration of water (55.4 M at
25 °C), and RT = 0.592 kcal/mol at 25 °C.
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Equations 6 DQ

Dual fluorescence quenching experiments with acrylamide and 10DN. Membrane insertion
of Trp residues was determined by fluorescence spectroscopy. The samples were contained in a
4×4 mm2 rectangular quartz cuvette, with constant stirring. Excitation and emission slits were 4
and 10 nm, respectively. Tryptophans were selectively excited at 290 nm, and the emission
spectra were recorded between 300 and 400 nm, followed by spectral correction by subtracting
the spectra measured under identical conditions but without the protein or peptide. In
experiments of Trp fluorescence quenching with acrylamide, PLA2 or peptide solutions were
prepared in buffers that contained 1 mM EDTA, 50 mM HEPES (pH 7.4) and varying
concentrations of acrylamide, emission spectra were measured, maximum fluorescence
intensities without and with the quencher (F0 and F respectively) were determined, and F0/F
values were plotted against the acrylamide concentration.
The slopes of the best-fit linear plots were used to determine the Stern-Volmer quenching
constants (KSV). The experimental data were fitted with the Stern-Volmer equation

F0
= 1 + K SV [Q ]
F

(Eq. 13)

where [Q] is the quencher concentration. The total concentration of the lipid, when present, was
0.5 mM.
In dual quenching experiments, Trp emission intensity was measured in the presence of lipid
vesicles with no quencher (F0), in the presence of vesicles and with 250 mM acrylamide in the
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buffer (Facrly), and in the presence of vesicles containing 10 mol% 10DN with no acrylamide in
the buffer (F10DN). The dual quenching ratio, RDQ, was determined as described earlier 154; 155:

RDQ =

F0 / Facryl − 1

(Eq. 14)

F0 / F10 DN − 1

Values of RDQ < 1 indicate that the fluorophore is efficiently shielded from the aqueous phase by
membrane insertion, while exposure of the fluorophore to the aqueous phase yields RDQ >> 1.
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Equations 7 Br2PC

Depth dependent Trp quenching by Br2PC labeled vesicles. The depth of membrane
insertion was quantitatively determined by using differential quenching of Trp fluorescence by
Br2PCs brominated at 6,7-, 9,10-, or 11,12-, positions of the sn-2 acyl chain. Br2PCs were
incorporated in vesicles at 20 mol%. Initially, Trp fluorescence spectra of the protein or the
peptide were measured in the presence of lipid vesicles composed of POPC and POPG, and the
emission intensity at 350 nm was measured and designated F0. Then, Trp emission intensities at
350 nm (F) were measured in the presence of vesicles in which 20 mol% of POPC was replaced
by each of the three Br2PCs. The values of ln(F0/F) were calculated and plotted against the
distance of the bromine atoms from the membrane center, i.e., 11.0, 8.3, and 6.5 Å for 6,7-, 9,10, and 11,12- Br2PCs, respectively 88. The experimental data were described using the distribution
analysis 156; 157:

ln

⎡ ( h − hm ) 2 ⎤
F0
S
=
exp ⎢ −
⎥
F σ 2π
2σ 2 ⎦
⎣

(Eq. 15)

In Equation 15, S is the area under the distribution curve and is directly proportional to the
degree of the exposure of the fluorophore to the quencher, σ is the dispersion of the distribution
curve and is determined by the sizes of the fluorophore and the quencher, as well as by structural
disorder and heterogeneity of the system, h is the distance from membrane center, and hm is the
most probable location of the fluorophore with respect to the membrane center.
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Equations 8 CD

Ten scans were averaged between 260 and 180 nm and corrected for the background
signal by subtracting the spectra of the appropriate control samples without protein. The mean
residue molar ellipticity, [θ], was calculated as:

[θ ] =

θmeas
cnresl

(Eq. 16)

where θmeas is the measured ellipticity in millidegrees, c is the molar concentration of the protein,
nres is the number of amino acid residues in the protein, and l is the optical path-length in mm.
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Equations 9 ATR-FTIR

Polarized amide I spectra cannot be used for determination of protein secondary
structure, because the intensities of amide I components corresponding to different secondary
structures depend not only on their content in the protein but also on their orientation relative to
the electric vector of the plane-polarized light

116; 158

. Figure 39 illustrates the general

relationship between an oriented membrane bound protein with two alpha helices to the ATRFTIR system of polarized light, evanescent field and electric vector components Ex, Ey and Ez..

Figure 39 Internal reflection element
Illustration of the path of a single beam of parallel polarized infrared light reflected on the internal faces
of a germanium plate: γ is incident angle of the incoming light; EII and E┴ are the electric vectors for
parallel and perpendicular polarizations, respectively. The orthogonal components of the electric vector of
the evanescent field are Ex, Ey, and Ez. The evanescent field is generated at the point of internal reflection
and exponentially decays in the EZ direction with a decay length of approximately 300 nm. A single
enzyme is placed on the surface of the plate in order to demonstrate the relative orientation of the two
helices to EZ.

The spectra measured at parallel and perpendicular polarizations can be used to obtain a
“polarization-independent” spectrum:
118

A = AII + GA⊥

(Eq. 17)

where G is a scaling factor and under our experimental conditions G = 0.8 (see Ref. 158 for more
detail). Following spectral correction, the secondary structure content can be presented as a
fraction of the total amide I area:

fss = Acomp/Atotal

(Eq. 18)

where fss is the fraction of the secondary structure component, Acomp is the area of the amide I
secondary structure component, while Atotal is the total amide I area 116; 158.
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Equations 10 HDX

Initiation of amide HDX by exposure of the protein to D2O results in a shift of amide II
band from ~1545 to ~1450 cm-1, allowing determination of the HDX kinetics based on the
gradual reduction in the intensity of amide II band around 1545 cm-1. We have conducted the
HDX experiments in the presence of EGTA to prevent lipid hydrolysis and the effect of
continuously changing membrane structure on the HDX kinetics. The fraction of unexchanged
amide protons at time t of exposure of the protein to D2O is determined as:

Ht
A
= t
H t + Dt A0

(Eq. 19)

where Ht and Dt are the numbers of unexchanged and exchanged amide protons at time t, A,0 and
At are the normalized integrated amide II band areas measured at ~1545 cm-1 before and at time t
of exposure to D2O, respectively. In order to eliminate the effects of possible changes in the
overall signal, e.g. due to protein adsorption or desorption, the amide II bands were normalized
by dividing by the integrated amide I areas at corresponding time points:

⎛A
At = ⎜⎜ amideII
⎝ AamideI

⎞
⎟⎟ ,
⎠t

⎛A
A0 = ⎜⎜ amideII
⎝ AamideI

⎞
⎟⎟
⎠0

(Eq. 20)
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Since the HDX kinetics reflect solvent accessibility and the strength of H-bonding in the protein,
this implies that all protein residues can usually be divided into a small number of populations
with similar dynamic properties therefore the HDX kinetics is described by a double-exponential
function 116; 124:

Ht
A
= t = a0 + a1e − k1t + a 2 e − k2t
H t + Dt A0

(Eq. 21)

where a0, a1, and a2 are the fractions of exchange-resistant, slow exchanging, and fast
exchanging residues; and k1 and k2 are the rate constants of the slow and fast exchanging
populations, respectively.
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Equations 11 ATR Dichroic Ratio

The ratio of absorbance intensities at parallel and perpendicular polarizations of the incident light
yields the ATR dichroic ratio:
R AIATR =

AI II
AI ⊥

which is determined by the orthogonal components of the electric vector of the evanescent field,
Ex, Ey, Ez, and the orientational order parameter of the aligned sample (Figure 39). For an
isotropic sample, one that is not oriented in a specific manner but is randomly oriented about the
z axis, the dichroic ratio is:

RISO =

E X2 + EZ2
EY2

Riso ≈ 1.72 for a lipid membrane supported on a germanium plate in aqueous environment at an
incident angle of the incoming light γ = 45 degrees
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(Figure 39). If the effect of the lipid

bilayer on the evanescent field is neglected, which may be justified because of its diminutive
thickness

159

, then Riso ≈ 2.0. This latter consideration is known as a two-phase approximation,

while the one that takes the membrane refractive index into account is known as a three-phase
approximation. For an α-helix, RATR values lower or higher than Riso indicate horizontal or
vertical orientation of the helix axis relative to the membrane plane, respectively. The physically
meaningful limits of RATR are 1.3-3.6 and 1.4-4.5 for the three-phase and the two-phase
approximations, respectively.
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Equations 12 Order Parameter

S: Orientation of alpha helices to the membrane normal. Values of RαATR can be used to
determine the α-helical order parameters, S, by the equation:

S=

2B
(3 cos α − 1)( B − 3E z2 )

(Eq. 22)

2

Where
B = E x2 − RαATR E y2 + E z2

(Eq. 23)

In these conditions, Ex = 1.9684, Ey = 2.25 and Ez = 1.8906. The angle α is the angle between the
amide I transition dipole moment and the alpha helix axis = 38° 160; 161. (Figure 40)

Figure 40 Order parameter
The relationship between an alpha helix, the amide I transition dipole moment and the orthogonal electric
vector components, Ex; Ey and Ez. The transition dipole moment is generated by the characteristic alpha
helical hydrogen bonding, illustrated by the carbonyl group, the amide group is not shown.
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The order parameter can be interpreted in terms of an average angle, θ, (Figure 40) between the
helical axis and the membrane normal (EZ) using the equation:

S=

(

)

1
3 cos 2 θ − 1 .
2

(Eq. 24)

Physically meaningful values of the order parameter (S) vary between –0.5 and +1.0,
which correspond to orientations parallel and perpendicular to the membrane plane, i.e., θ = 90°
and 0, respectively, while an order parameter close to zero may indicate either a random,
isotropic orientational distribution or a fixed orientation at θ = 54.7°.
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APPENDIX B: ALGORITHM
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Determination of interhelical angles

The main mathematical operation utilized in this algorithm is coordinate transformation
between two orthogonal coordinate systems, the “protein” system Σp with axes X*Y*Z*, in
which the protein atom coordinates are given, and the “intrinsic” helical coordinate system Σh
with axes XHYHZH that are assigned to each helix, with ZH being the helical axis. The
backbone atom coordinates of an α-helix in the system Σh can be given as:

x H i j = a cos[100( j − 1)]⎫
⎪
⎪
y H i j = a sin[100( j − 1)] ⎬
⎪
z H i j = b( j − 1)
⎪⎭

(S1)

where a is the radius of the helical “cylinder” and b is the height per residue (in the following
text, the upper case X, Y, and Z will denote the coordinate axes and the lower case x, y, and z
will mean the coordinates). This applies to any set of backbone atoms, with corresponding
parameter a (b is a constant for a given type of helix). For example, if Cα atoms are considered
(Cα atoms are on the surface of the helical “cylinder”), then for an α-helix a = 2.25 Å and b = 1.5
Å. In the equation system (S1), the subscript i signifies a certain (ith) helix in the protein
molecule and j signifies a certain (jth) amino acid residue in ith helix, moving in an N→C
direction. First, we ascribe a “base” to all helices, i.e., a circle that constitutes the base of the
helical “cylinder”. We translationally move all helices so that the centers of all “bases” coincide
with the origin of the Σp coordinate system. Note that the initial coordinates of these centers are
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0, 0, 0 in the Σh system and x0i, y0i, z0i in the Σp system. If the atom coordinates in the Σp system
originally were x*ij, y*ij, z*ij, now they become x*ij- x0i, y*ij- y0i, z*ij - z0i. We express the
backbone atom coordinates in the intrinsic helical coordinate systems Σhi through the coordinates
in the protein system Σp by means of coordinate transformation:

x H i j = ( x *i j − x 0 i ) cos( X *, X H i ) + ( y *i j − y 0 i ) cos(Y *, X H i ) + ( z *i j − z 0 i ) cos( Z *, X H i ) ⎫
⎪
⎪
y H i j = ( x *i j − x 0 i ) cos( X *, YH i ) + ( y *i j − y 0 i ) cos(Y *, YH i ) + ( z *i j − z 0 i ) cos( Z *, YH i ) ⎬
⎪
z H i j = ( x *i j − x 0 i ) cos( X *, Z H i ) + ( y *i j − y 0 i ) cos(Y *, Z H i ) + ( z *i j − z 0 i ) cos( Z *, Z H i ) ⎪
⎭

(S2)

Here, cos(A,B) means the cosine of the angle between the positive directions of the axes A and
B. For a given helix, we can write each of the three equations of the system (S2) for four
consecutive residues, starting at the first residue in the helix. This, combined with the equation
system (S1), yields (S3):

a cos[100( j − 1)] = ( x *i j − x0 i ) cos( X *, X H i ) + ( y *i j − y 0 i ) cos(Y *, X H i ) + ( z *i j − z 0 i ) cos( Z *, X H i )⎫
⎪
a sin[100( j − 1)] = ( x *i j − x0 i ) cos( X *, YH i ) + ( y *i j − y 0 i ) cos(Y *, YH i ) + ( z *i j − z 0 i ) cos( Z *, YH i ) ⎪
⎪
b( j − 1) = ( x *i j − x 0 i ) cos( X *, Z H i ) + ( y *i j − y 0 i ) cos(Y *, Z H i ) + ( z *i j − z 0 i ) cos( Z *, Z H i )
⎬
⎪
j = k , k + 1, k + 2, k + 3
⎪
⎪
k = 1,2,..., m − 3
⎭

In the system (S3), m is the number of residues in the helix. If protein backbone atom
coordinates x*ij, y*ij, z*ij are known, for a given helix the system (S3) represents 12 equations
with 12 unknowns, i.e., the nine cosines and the coordinates x0i, y0i, z0i. The system (S3) can be
solved as follows. Each of the three equations of the system can be written in quadruplet, i.e., for
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consecutive residues j = 1 to 4, or j = 2 to 5 and so on up to the end of the helix. Note that this
can only be done if the helix involves at least four residues. The equation corresponding to j = k
can then be subtracted from those corresponding to j = k + 1, k + 2, k + 3. This yields the
following system (S4):

100( j + k − 2)
100(k − j )
⎫
sin
= Δx *ijk cos( X *, X H i ) + Δy *ijk cos(Y *, X H i ) + Δz *ijk cos( Z *, X H i )⎪
2
2
⎪
100( j + k − 2)
100( j − k )
2a cos
sin
= Δx *ijk cos( X *, YH i ) + Δy *ijk cos(Y *, YH i ) + Δz *ijk cos( Z *, YH i ) ⎪
⎪
2
2
⎪
b( j − k ) = Δx *ijk cos( X *, Z H i ) + Δy *ijk cos(Y *, Z H i ) + Δz *ijk cos( Z *, Z H i )
⎬
⎪
k = 1,2,...m − 3
⎪
⎪
j = k + 1, k + 2, k + 3
⎪
⎪
⎭
2a sin

In system (S4), Δx *ijk = x *ij − x *ik , ( Δy *ijk and Δz *ijk are given by similar expressions). Any
of the three equations of the system (S4) then can be written in triplet, i.e., for k = 1, 2, 3, or k =
2, 3, 4 and so on, and each triplet can be solved to find the three cosines, using the Cα (or other
backbone atom) coordinates and the corresponding parameter a or b of the helix. For example,
completion of this procedure for an α-helix of the protein using the third equation of the system
(S4) will yield cosines that describe the orientations of helical axes (ZHi) for overlapping
stretches of that particular helix with respect to the protein coordinate system Σp. In other words,
we will learn the orientations of helical segments formed by helical residues 1 to 4, 2 to 5, 3 to 6
and so on. Using the backbone atom coordinates of the protein, we solve the system (S4) for all
helices of the protein.
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This procedure allows characterization of helices in several respects. First, plots of
cos(X*,ZHi), cos(Y*,ZHi), and cos(Z*,ZHi) against the number of residues in a helix will indicate
the degree of deviation of the helical axis from linearity. Deviations of the cosines from a
constant value will identify helix bending at certain positions and will quantitatively describe the
bending. High degree of “noise” in these plots will indicate distorted helices, and vice versa.
Second, the average values of the cosines obtained for all helical segments will indicate the
average orientation of the entire helix within the protein molecule. If there is a major bend in the
helix, averaging of the cosines for segments before and after the bend will provide the bending
angle. Third, the data obtained for all helices of the protein will allow determination of the
angles between any two helices or between their segments of interest, as described below. This
will provide accurate quantitative information on the interhelical angles of the protein.
Besides orientational information, the algorithm also allows one to scan along the helix
and gain structural information on any four-residue sections of helices. The quality of helical
structure is determined by using the laws of direction-cosines for orthogonal concentric
coordinate systems:

⎧0, i ≠ k
cos δ i cos δ k + cos ε i cos ε k + cos ζ i cos ζ k = ⎨
⎩1, i = k

(S5)

where δ1,2,3 are the angles (X*,XH), (Y*,XH), (Z*,XH), ε1,2,3 are the angles (X*,YH), (Y*, YH),
(Z*,YH), and ζ1,2,3 are the angles (X*,ZH), (Y*,ZH), (Z*,ZH), respectively. Deviations of the
result from requirements of the equations (S5) will indicate deviations from a standard helical
structure described by given parameters a and b. Also, by changing these parameters, for
example, from those corresponding to α-helix to those corresponding to π- or 310- or other types
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of helix, one can identify local conformational transformations in the protein.
Now we show how the angle between the helical axes of any two helices of the protein
can be explicitly determined. Consider two helices, numbered i = 1 and i = 2. Following the
procedures described above, we determine the angles ζ1,1, ζ2,1, ζ3,1, and ζ1,2, ζ2,2, ζ3,2 that the axes
of these helices make with the axes X*, Y*, Z* of the protein coordinate system. We present
each helical axis by a unit vector originating at X* = Y* = Z* = 0, and consider two planes
perpendicular to these two unit vectors in a way that the tip of each unit vector is within
corresponding perpendicular plane. Each plane can be presented in the three-dimensional space
as:
Ai x + Bi y + C i z + Di = 0

(S6)

where
Ai =

1
1
1
1
, Bi =
, Ci =
, Di = −
cos ζ 2,i cos ζ 3.i
cos ζ 1,i cos ζ 3,i
cos ζ 1.i cos ζ 2.i
cos ζ 1,i cos ζ 2.i cos ζ 3,i

The angle θ between the two helical axes is the same as the angle between the two perpendicular
planes, which is given as:

cosθ =

(A

2
1

A1 A2 + B1 B2 + C1C 2

)(

+ B12 + C12 A22 + B22 + C 22

(S7)

)
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Determination of angular orientation: RαATR

The best way of presenting the mode of membrane binding of a protein is providing a file in
which the atom coordinates are given in an intrinsic “membrane” coordinate system Σm, such as
a Cartesian system with its XY plane coinciding with the membrane central plane between the
two lipid leaflets and with the Z axis perpendicular to the membrane surface. Here we describe
how this can be achieved by segmental isotope labeling and polarized attenuated total reflection
Fourier transform infrared (ATR-FTIR) spectroscopy. We consider two Cartesian coordinate
systems, the “membrane” system Σm, as specified above, and the protein system Σp with axes
X*Y*Z*, in which the protein atom coordinates are given. For determination of the angular
orientation of the membrane-bound protein, we need the cosines of angles between the axes of
the systems Σm and Σp when the protein is bound to the membrane. We used a PLA2 molecule in
which the N-terminal α-helix was not labeled whereas the two other helices H2 and H3, which
are nearly parallel to each other, are 13C-labeled. Segmental isotope labeling of PLA2 resulted in
a splitting of the infrared amide I band of the protein. The fact that H2 and H3 of the protein are
nearly parallel to each other allows us to ascribe a common order parameter to H2/3. Spectrally
separated amide I signals of the unlabeled H1 and the

13

C-labeled H2/3 at parallel and

perpendicular polarizations of the infrared light were used to determine two order parameters,
one for H1 and one for H2/3. This allowed determination of the cosines of angles between the
helical axes and the membrane normal, cos(ZZH1) = ± 0.489 and cos(ZZH2) = ± 0.252, where ZH1
and ZH2 are the helical axis of H1 and an axis describing the orientation of H2/3. Because of the
rotational freedom of the protein about the membrane normal (Z-axis), the plus and minus signs
of the cosines are equivalent. Then, orientations of helices in the membrane system Σm, i.e.
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cos(ZZH1) and cos(ZZH2), were expressed through the cosines of angles between the coordinate
systems Σm and Σp and orientations of helices in the protein coordinate system Σp:

cos(ZZH1) = l3u11 + m3u21 + n3u31

(S8

cos(ZZH2) = l3u12 + m3u22 + n3u32

(S9)

and

where l3 = cos(Z,X*), m3 = cos(Z,Y*), n3 = cos(Z,Z*), u1,i = cos(X*,ZHi), u2,i = cos(Y*,ZHi), u3,i
= cos(Z*,ZHi). All values of uij, i.e. the orientations of all helices relative to the axes of the
protein coordinate system Σp, were determined using the Cα atom coordinates of the protein, as
described in the preceding section. Equations (S8) and (S9) then contain three unknowns: l3, m3,
and n3, i.e. a third equation is needed to find these cosines. The third equation is simply given by
the law of direction cosines: l32 + m32 + n32 = 1. The three equations were solved together and
the values of cosines of the angles between the three axes of the protein coordinate system Σp and
the membrane normal were determined as l3 = -0.301, m3 = -0.256, n3 = 0.919. These cosines
determine the orientation of the membrane-bound protein with respect to the membrane normal
with an accuracy of ±180°. This is because molecules oriented at an angle α or α ± 180°
generate the same infrared linear dichroic ratio and order parameter.
Our task is to obtain the coordinates of the membrane-bound protein in the “membrane”
coordinate system Σm. In order to do this, the other six cosines, i.e. those of the angles between
the X and Y axes and the axes X*, Y*, and Z*, were needed in addition to where l3, m3, and n3.
Because of the rotational freedom of the membrane-bound protein about the Z-axis, all azimuthal
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angles (determined by rotation about the Z axis) are equally valid. Therefore, one of the six
cosines was arbitrarily selected [e.g., cos(Y,X*) = 0.456], and the other five cosines were found
using the laws of direction cosines (equations S5). This yielded l1 ≡ cos(X,X*) = -0.837 , l2 ≡
cos(Y,X*) = 0.456, m1 ≡ cos(X,Y*) = 0.532, m2 ≡ cos(Y,Y*) = 0.807, n1 ≡ cos(X,Z*) = -0.127,
n2 ≡ cos(Y,Z*) = 0.374. The nine direction cosines between the membrane and protein
coordinate systems, which were considered to be translationally co-centered, were used to
transfer the protein atom coordinates from the protein system Σp (xi*, yi*, zi*) to the membrane
system Σm (xi, yi, zi):

xi = l1 xi* + m1 y i* + n1 z i* ⎫
⎪
y i = l 2 xi* + m2 y i* + n 2 z i* ⎬
⎪
z i = l3 xi* + m3 y i* + n3 z i* ⎭

(S10)

These coordinates present the structure of the membrane-bound protein with an angular
orientation corresponding to the mode of membrane binding, but do not specify the translational
location of the protein relative to the membrane normal (coordinate transformation was done
suggesting that the systems Σm and Σp have a common origin). In order to locate the protein in
the vertical dimension (the membrane normal Z-axis), we have measured membrane depthdependent quenching of the single tryptophan (Trp3) of PLA2, and have adjusted all zcoordinates of protein atoms by simple translation so the geometric center of the indole ring of
Trp3 was located as determined by fluorescence quenching experiments.
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